Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 25, 2026.

Pharmaceutical Pollution in Aquatic Environments: A Concise Review of Environmental Impacts and Bioremediation Systems

Maite Ortúzar, Maranda Esterhuizen, Darío Rafael Olicón-Hernández and 2 more

Frontiers in Microbiology · 2022 · Review · CC BY

doi:10.3389/fmicb.2022.869332

Abstract

The presence of emerging contaminants in the environment, such as pharmaceuticals, is a growing global concern. The excessive use of medication globally, together with the recalcitrance of pharmaceuticals in traditional wastewater treatment systems, has caused these compounds to present a severe environmental problem. In recent years, the increase in their availability, access and use of drugs has caused concentrations in water bodies to rise substantially. Considered as emerging contaminants, pharmaceuticals represent a challenge in the field of environmental remediation; therefore, alternative add-on systems for traditional wastewater treatment plants are continuously being developed to mitigate their impact and reduce their effects on the environment and human health. In this review, we describe the current status and impact of pharmaceutical compounds as emerging contaminants, focusing on their presence in water bodies, and analyzing the development of bioremediation systems, especially mycoremediation, for the removal of these pharmaceutical compounds with a special focus on fungal technologies.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 25, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

In recent decades, the production and consumption of pharmaceutical products have rapidly increased with the development of medicine. Approximately 3,000 compounds are used as pharmaceuticals, and the annual production quantity exceeds hundreds of tons. Anti-inflammatory drugs, antibiotics, and analgesics are the most common drugs used around the world. Consequently, the emergence of water-soluble and pharmacologically active organic micropollutants or pharmaceutical active compounds (PhACs) has gained much attention worldwide. Humans use a variety of these pharmaceuticals for their health in everyday life, but large quantities of these drugs are also used as veterinary medicine on farms around the world, to prevent and treat animal diseases and to increase economic benefits in intensive livestock.

After ingestion, pharmaceuticals are excreted in urine and feces as active substances or metabolites. These pharmaceuticals are present in both influent and effluent wastewater but can also be found in surface water bodies, including freshwater ecosystems and marine environments, as well as in groundwater due to effluent leachates generated under recharge conditions. The main concern is that conventional treatment plants are ineffective in removing some of these emerging contaminants (ECs), and new techniques are being sought and studied to achieve their total elimination, particularly advances in mycoremediation. The importance of the study of pharmaceuticals lies in the massive increase in their consumption worldwide, as well as in the environmental repercussions that this entails, including their recalcitrance in aquatic and terrestrial ecosystems. In the contexts of wastewater and bioremediation, pharmaceutical compounds are considered as ECs due to the lack of regulation for their environmental disposal, as well as the lack of information regarding their long-term effects on the environment, which remains unknown. The fact that some drugs are marketed without medical prescription or pre-registration and, therefore, are widely consumed worldwide, meaning that they are widely distributed in the environment, has contributed to this growing problem.

Considering pharmaceuticals as ECs and the continual production of new PhACs, this review aims to comprehensively present the pharmaceuticals commonly detected in water, surface and groundwater and their adverse environmental effects. Advances in bioremediation technologies, which can be used as add-on treatments in wastewater treatment plants (WWTPs) to reduce unprocessed pharmaceuticals released via effluent into the environment, are presented and critically discussed with an emphasis on mycoremediation.

Common Pharmaceuticals Detected in Water (Surface and Groundwater)

Pharmaceutical compounds that reach water bodies, both surface water and groundwater, came from a number of different sources (Figure 1). The first of these is urban wastewater, which contains a high load of pharmaceuticals from human excrement, and also the inadequate disposal of expired or unused drugs due to the scarce control in their management. Another major source of pharmaceuticals is agricultural and livestock waste, especially the latter, since in large farms for intensive livestock, animals are often fed with feed supplemented containing drugs and excreta are often used in agriculture as soil amendments, reaching groundwater by leaching. Effluents from the pharmaceutical industry are another important source, with high concentrations of pharmaceuticals being found due to discharges from factories in Asia, Europe and America, despite strict regulation of pharmaceutical production in Europe and the United States. These industries are obliged to carry out treatment before discharge into the general urban sewer network.

Pharmaceuticals found in high concentrations in wastewater include non-steroidal anti-inflammatory drugs (NSAIDs), β-blockers ad psychoactive compounds, analgesics, antibiotics, endocrine disruptors, antiretroviral drugs, and drugs to treat cancer. These are the PhACs most commonly detected due to the analytical methods available and their resolution, although new methods for identifying these compounds are increasingly being developed. Table 1 shows the worldwide distribution of the drugs most commonly found in water (Supplementary Figure 1).

Non-steroidal anti-inflammatory drugs and analgesics are some of the most important groups of pharmaceutical products worldwide, with diverse chemical structures and similar therapeutic effects, having an estimated annual production of several hundred tons. Large amounts of anti-inflammatory drugs are prescribed in human care, but they are often sold in much higher amounts without a prescription. NSAIDs and analgesics are often combined with antibiotics in veterinary medicine for problems such as pain, inflammation, fever, osteoarthritis and arthritis, and to reduce stress. However, these two types of pharmaceuticals have numerous adverse effects in humans, including gastrointestinal disturbances, ulceration, renal failure with increased risk of post-operative bleeding, asthma, and rare allergic reactions. Approximately 35 million people use NSAIDs every day worldwide, and China increased its domestic production from 41,537 t in 2013 to 46,673 t in 2017. They are currently monitored in effluents worldwide to check these drug concentrations and several studies show that both NSAIDs and analgesics are commonly detected in water bodies. In Cuernavaca (Mexico), high concentrations of naproxen (732–4,889 ng/L), acetaminophen (354–4,460 ng/L), and diclofenac (258–1,398 ng/L) have been detected in samples collected in different years, in the influent and effluent of a WWTP and in the surface waters of the Apatalco River. Furthermore, the drugs diclofenac (10,221 ng/L highest concentration detected) and acetaminophen (1234-2346 ng/L), among others, have been detected in effluents from the Red Sea (Saudi Arabia). On the other hand, in Brazil, acetaminophen (17.4–34.6 ng/L), diclofenac (19.4 ng/L), and ibuprofen (326.1–2,094.4 ng/L) have been detected in the surface and bottom water samples from Santos Bay. These same drugs have also been detected in surface water on the northern Antarctic Peninsula region due to increased tourism in this area, with concentrations of 48.74, 15.09, and 10.05 ng/L of acetaminophen, diclofenac, and ibuprofen, reported respectively.

Among the pharmaceutical compounds found in wastewater, antibiotics are of the greatest concern due to their persistent nature, partial metabolism, and easy movement through ecosystems. Antibiotic production in China was approximately 92,700 tons, 48% destined for humans and the remaining for livestock; a total of 46% active metabolites were produced. The antibiotics most commonly found in wastewater are sulfonamides, quinolones, tetracyclines, fluoroquinolones, and nitroimidazoles. The total concentrations of antibiotics vary depending on the body of water, in the case of wastewater, they can range between 0.0013 and 0.0125 μg/mL, in drinking water 0.0005 and 0.0214 μg/mL and river water 0.0003 and 0.0039 μg/mL. Antibiotic resistance of microorganisms to antimicrobials is becoming even stronger and more widespread over time and is expected to greatly increase human morbility and mortality in the near future. Antibiotics have been found in rivers all over the world, including several in Spain (Ebro, Guadarrama and Manzanares Rivers), Italy (Arno River), South Korea (Han River), Taiwan (Xindian, Gaoping, Dahan and Po River), France (Seine River), United States (Ozark River), Sweden (Hoje River), and China (Pearl, Hai, Liao and Yellow Rivers).

Endocrine disruptors were defined in 2002 by the International Programme on Chemical Safety (IPCS) of the United Nations Environment Programme (UNEP) and by the World Health Organization (WHO) as “an exogenous substance or mixture that alters the function(s) of the endocrine system and consequently causes adverse health effects in an intact organism or population”. Among the most common endocrine disruptors are pesticides, bisphenols and natural hormones. These substances are not removed from water by conventional treatment processes and are found in wastewater bodies in the order of nanograms to micrograms per liter.

Antiretroviral drugs are frequently used to treat the human immunodeficiency virus (HIV), an epidemic that has developed worldwide and has its epicenter in South Africa. As a result, millions of people have access to these drugs on a daily basis, with more than 40 different antiretroviral drugs being used for the treatment of HIV. These include abacavir, efavirenz, lamivudine, nevirapine, tenofovir, and zidovudine; many of which are used in combination. As a consequence of the increase in the rate of HIV infection over the years, there has been a significant increase in the production and consumption of antiretroviral drugs worldwide. In addition, as consequence of the new pandemic coronavirus (COVID-19), antiretroviral drugs have also been used for the treatment of SARS-CoV-2. In some countries, such as China and Japan, clinical trials have been conducted to test the efficiency of using HIV drugs to treat COVID-19. At the moment, a scarcity of studies has dealt with this new issue. However, some studies have started to show a relevant problem that we will have in the very near future.

In the coming decades, annual cancer cases are expected to increase to more than 20 million, which means an exponential increase in anticancer drugs and their subsequent release into wastewater. Most of these compounds are incompletely assimilated and metabolized by the human body, thus excreted in feces and urine. The most commonly administered anticancer drugs include cyclophosphamide, tamoxifen, ifosfamide and methotrexate, among others. These drugs have been detected in surface water, WWTP effluents and influents, and hospital effluents. Detected concentrations of cyclophosphamide range from 0.05 to 22,100 ng/L, ifosfamide 0.14–86,200 ng/L, methotrexate 1.6–4,756 ng/L, and tamoxifen 0.01–740 ng/L. Several studies have detected these drugs in water masses, confirming that current water treatment systems fail to degrade them. Different international agencies have developed protocols for the handling and storing of pharmaceuticals to reduce their harmful effect on the environment. One of the main concerns is that these drugs may suffer biomagnification.

Impact of Pharmaceuticals on the Environment and Living Organisms

Since almost all drugs are not completely metabolized by organisms (usually a small fraction of the active site of drug metabolic enzymes are occupied, the half-life of drugs are limited, and drugs are administrated in higher amounts than necessary to increase efficiency), the compounds that can cause the most damage once they are excreted and reached wastewater are PhACs. They are also called active pharmaceutical ingredients or APIs and metabolites, referring to the molecules resulting from these original compounds due to structural changes that take place in organisms. In addition, the resulting molecules are also subject to changes in the environment (such as oxidation, photolysis, or biotransformation). These changes can occur through both biotic and abiotic processes. Thus, many pharmaceutical products are biotransformed by microorganisms. Ecotoxicologists are increasingly concerned about the worldwide detection of pharmaceutical residues in aquatic environments since their long-term toxic effects are being increasingly studied. However, it is challenging to know these effects because of the short time period these substances have been present in the environment.

Different studies analyzed the microbiome of wastewater where, in the case of hospitals, an abundance of anaerobes related to pathogenic threats such as Bifidobacteriales, Bacteroidales, and Clostridiales was found. They also noted that compared to other locations, hospital wastewater contains microorganisms with higher relative levels of antimicrobial and antibiotic resistance genes. The mycobiome of hospital wastewater has also been analyzed, indicating the presence of different opportunistic phyla such as Mycosphaerella, Drechslera, Candida, or Cyphellophora, whose risk that they may acquire resistance to antibiotics is of great concern and may have great repercussions for global health.

Beta-Blocker and Psychoactives

β-blockers are a group of pharmaceuticals that are commonly detected in the environment. This is because many wastewater plants are not adapted to remove these micropollutants. Detected concentrations vary from 3 to 6,167 ng/L, which are already sufficient to cause neurotoxic and reproductive disorders in living organisms. Bisoprolol causes immobilization in Daphnia similis and mortality in fish and green algae. Propranolol causes growth and development problems in algae such as Synechococcus leopolensis and Cyclotella meneghiniana, mortality in crustacea (Ceriodaphnia dubia), and embryonic development problems in Danio rerio.

Psychoactive substances affect thought, emotion, will and behavior. According to their pharmacological properties, psychoactive substances (including legal and illegal drugs) are opioids, cannabis, central nervous system depressants, central nervous system stimulants, hallucinogens, and tobacco. These substances have different effects on humans, such as analgesia, anesthesia, inability to concentrate, excitement, anxiety, and mania. indicated that ecological risk assessment is a crucial part of research on psychoactive substances, as the current relevant literature is scarce. Due to the biological activity of such substances, there is a need for rapid improvement of risk assessment, including acute, cone and developmental toxicity, neurotoxicity, and endocrine-disrupting effects, among others, as well as the development of remediation technologies.

Non-steroidal Anti-inflammatory Drugs and Analgesics

Pharmaceuticals are known to have biological effects on living organisms, but there is not enough information currently available to assess the possible ecotoxicological impacts. Below are some of the toxic and ecological risks of NSAIDs and analgesics, according to various studies and summarized in Table 2: (I) population declines of Gyps vultures in Asia due to high diclofenac concentration; (II) diclofenac impairs prostate gland synthesis and damage to the gills, liver, and kidneys of Salmo trutta f. fario; (III) histological alterations of the kidneys and gills, cytological alterations of the liver, kidneys, and gills, and deterioration of ionic regulation in Oncorhynchus mykiss; (IV) ibuprofen, diclofenac, naproxen and ketoprofen inhibits CYP2M in Cyprinus carpio; (V) ibuprofen change breeding pattern of Oryzias latipes; (VI) ibuprofen, diclofenac, and acetaminophen cause cardiovascular abnormalities, hatch and motor behavior and interruption of oocyte maturation/ovulation in D. rerio; (VII) diclofenac alters estrogenic activity, response of specific tissue biomarkers, decreased superoxide dismutase, and glutathione reductase activities in gills, and high catalase activity and levels of lipid peroxidation in the digestive gland in Mytilus galloprovincialis. As can be inferred, high concentrations of NSAIDs and analgesics in the environment, such as acetylsalicylic acid, acetaminophen, diclofenac, ibuprofen, and naproxen, cause serious environmental problems. In addition to fish, the main organisms affected are invertebrates, including arthropods, mollusks, cnidarians and rotifers. NSAIDs also affect the plant growth of species such as Pisum sativum and Vigna unguiculata (;; Table 2).

Antibiotics

Due to the continuous introduction of antibiotics into the environment, aquatic and soil organisms are chronically exposed to these drugs. Moreover, because they are active at very low concentrations, they have a toxic effect on organisms, and there is a synergistic effect when they are present together with other drugs and/or xenobiotic compounds. Algae and aquatic plants are severely affected by antibiotics. Many of them have been found to be photosynthesis inhibitors, as they can block the electron chain of photosystems II and increase oxidative stress. However, microorganisms, including bacteria and fungi, are developing resistance to antibacterial substances due to exposure to low concentrations over several generations. Invertebrates such as Hydra attenuata and crustaceans such as Artemia salina, Daphnia magna, and Ceriodaphnia dubia show relatively low acute toxicity in the presence of antibiotics. On the other hand, in fish, acute toxicity was only found at high concentrations, but there were cases in which no toxicity was observed (;;; Table 2). The other major problem is antibiotic resistance genes (ARGs), which are genes that confer antibiotic resistance to bacteria, and can proliferate through the reproduction of antibiotic-resistant bacteria from the host or through horizontal gene transfer, are present in the environment, and thus considered as emerging environmental contaminants. Although treated wastewater contains significantly lower amounts of ARGs than untreated wastewater, several studies show that aquatic environments downstream of treatment plants can increase the amounts of ARGs because they are carried by mobile genetic elements, such as conjugative plasmids, integrative and conjugative elements, and transposons and integrons. These effective carriers of ARGs could confer multi-resistance. One of the most detected genetic components in both effluents and aquatic environments is Class 1 integron-integrase gene (intI1) associated more frequently with ARGs and involved in horizontal gene transfer.

Endocrine Disruptors

Endocrine disruptors seriously affect both human and animal health, as they act directly on the endocrine system and block or mimic the natural hormones responsible for the functioning of some organs. These substances have been studied extensively in humans, nevertheless, much less in the environment. It is known that they can alter the reproductive system, cause Alzheimer’s disease, thyroid problems, obesity and/or cancer (prostate, breast or endometrium cancer), among others. In natural ecosystems, the reproductive system is also affected, as well as the levels of vitellogenin and hatchability and thus feminization with the consequent threat to the preservation of biodiversity (;; Table 2).

Antiretrovirals

In contrast to other pharmaceuticals, antiretrovirals, despite being abundant in wastewater, are poorly monitored, although some studies report on them. These drugs could pass through treated wastewater in WWTPs, reach drinking water sources, and cause serious ecotoxicological problems for human health. Currently, the greatest concern is that resistant strains of HIV can be created in the body through exposure to water contaminated with these drugs (;; Table 2).

Anticancer Drugs

Although anticancer drugs are designed to eliminate fast-growing cells, such as tumor cells, many of these drugs are not selective. This means that in addition to attacking healthy cells, they can cause cytotoxic, genotoxic, mutagenic, and teratogenic effects, i.e., cause adverse effects in any eukaryotic organism. For this reason, anticancer drugs are considered to be of great environmental concern, and especially the groups at greatest risk are children, pregnant women, and the elderly. It has been shown that chronic exposure of two generations of D. rerio to anticancer drugs caused histopathological changes in the liver and kidney and impaired the integrity of their DNA, introducing massive changes in the entire transcriptome (;; Table 2).

Residues of pharmaceuticals in the environment typically occur as complex mixtures and even if the concentrations of an individual compound are low, the “cocktail effect” could be of significant ecotoxicological importance. To date, many works have focused on the study of individual organisms and analyzed a single drug or several drugs as a whole, but there are no works studying the impact of drugs on several populations simultaneously. This would provide essential information on ecotoxicity and the “domino effect” that affects individuals in a trophic chain since, in addition to bioaccumulation, the chain could be broken because a drug lethally affects a group of individuals.

Development of Bioremediation Technologies

Improving technologies for drug elimination from wastewater is an important task since pharmaceuticals have been detected in effluent from WWTPs and consequently surface water, groundwater, and drinking water globally. Although the pharmaceuticals are found in concentrations ranging from the nanogram to microgram per liter, which is too low to cause acute toxicity, they are biologically active compounds that have the potential for chronic toxicity, bioaccumulation, and biomagnification. Additionally, microplastics have been shown to serve as vectors for pharmaceuticals, thus increasing the exposure potential. Because of incomplete elimination during conventional wastewater treatment and the potential risk posed to the environment, as discussed above, there has been pronounced interest in developing alternative treatments in recent years, specifically the biological transformation of these pollutants as a green technology. The future inclusion of bioremediation technologies in traditional WWTP treatments is progressive as it will result in the detoxification of hazardous substances, it is less disruptive to the environment than harsh oxidative chemicals, and more cost-efficient. With perseverance, research into optimization could result in the complete eradication of target pollutants, rooting out release into the environment.

The wastewaters containing PhACs and their metabolites reaching WWTPs are commonly treated via purification systems. The potential of drug remediation via biological treatment utilizing microbes has been demonstrated. Biological systems are often used in conjunction with advanced treatments and combined with conventional activated sludge (CAS) systems due to limitations associated with the process. Advanced biological treatments include modified CAS, aerobic granular systems, moving bed bioreactors (MBBRs), anammox systems, and membrane bioreactors (MBRs). However, some of these processes, such as MBRs, could result in the generation of biosolids or sewage sludge as byproducts of required maintenance. Sewage sludge, after different stabilization processes such as thermophilic anaerobic digestion, continues onto different processes, such as composting, which could facilitate the transfer of PhACs and their metabolites into various trophic levels of the food web when used as a soil amendment.

Bioremediation, utilizing native microbial monocultures or consortia or bioaugmentation, has been used for decades as a sustainable technology to manage anthropogenic pollution. The advantages of bioremediation include less input of hazardous chemicals, energy, and time, and it is cheap relative to other technologies. The major benefit of bioremediation is that the pollutant is chemically transformed and not only shifted from one environment to another. However, a significant criticism of bioremediation has been that the remediation speed does not meet the requirements for the treatment capacity. Nonetheless, considering the benefits of the approach, attempts on optimizing the efficiency and decreasing retention times are being made and are reviewed below for mycoremediation. Developments in phyto- and phycoremediation of pharmaceuticals have been reported and recently reviewed and thus, not included here.

Bacterial remediation has been reviewed to some extent, and, therefore, a brief overview of previously undiscussed advances are included here alongside mycoremediation. Bacterial communities have the ability to degrade and mineralize many xenobiotic compounds and have thus been used for centuries in wastewater-activated sludge. Bioremediation technologies have been advanced by studies elucidating the importance of facilitating biofilm growth in achieving maximum efficiency and community stability and survival. The majority of the available literature on bacterial remediation has focused on the aerobic degradation of pharmaceuticals by individual bacteria or consortia in which oxygenases are reported to be involved. Activated sludge, in which an uncharacterized bacterial consortium in suspension is responsible for the remediation, is one of the most widely used biological methods to treat pharmaceutical wastewater at a large scale. However, due to operational issues associated with the development of large amounts of sludge, research has been invested in developing bespoke bacterial consortia for remediation, including microalgae and bacterial-microalgae consortia.

In the environment, fungi are excellent decomposers through the nonspecific nature of enzymes, both intracellular and extracellularly secreted, which exhibit significant capabilities to degrade organic material. More specifically, the ligninolytic (including peroxidases and laccases) and cytochrome P450 systems have been proven to be involved in the exceptional capacity of white-rot fungi to degrade recalcitrant pollutants. The nonspecific nature of these enzymes also makes them an ideal approach to deal with the diverse chemical structures of the many classes of pharmaceuticals. Many fungal species are also hyperaccumulators, capable of absorbing and bioaccumulating xenobiotics from their environment, as demonstrated by the ability of mushrooms. Furthermore, fungi are known for their capacities to adapt to severe environmental constraints, making them more tolerant to environmental changes than other bioremediation organisms. Thus, mycoremediation, which results in the reduced toxicity of wastewater, offers a comparatively cost-effective, eco-friendly, and effective approach to pollution remediation.

Macromycetes, aka mushrooms or polypores, were previously proven efficient in remediating various pharmaceuticals, including β-blockers and psychoactive drugs, anti-inflammatory drugs, antibiotics and hormones (Table 3). Mostly, investigations into the efficiency of fungi to remediate pharmaceuticals have been performed in flask batch experiments with white-rot fungi, especially Trametes versicolor, which exhibited impressive capacities for eliminating a vast range of pharmaceuticals. In bioreactors-based studies, T. versicolor was equally efficient, able to degrade various pharmaceuticals, including codeine, diazepam, carbamazepine, and metoprolol. The role of redox-mediators has also been extensively studied in improving the performance of laccase-based treatments, including the treatment of pharmaceuticals. Studies employing filamentous micromycetes have shown potential for pharmaceutical remediation from wastewaters as reviewed by but are limited compared to the literature on macromycetes (Table 3). The efficiency of bacteria and fungi to remediate different classes of pharmaceuticals is discussed in more detail below.

Beta-Blockers and Psychoactive Drugs

Carbamazepine, which is not adequately eliminated via standard wastewater treatments and is thus frequently detected in the environment, has been reported to be degraded by the macromycete T. versicolor. By employing T. versicolor, achieved 94% degradation of carbamazepine (9 mg/L) after six days in flask experiments. With a reduced concentration (50 μg/L), reported a lower remediation percentage of 61% achieved in seven days. The same group evaluated the fungus’s remediation efficiency of carbamazepine in an air pulsed fluidized bed bioreactor operated in batch and continuous mode. In batch mode, 96% of the drug was eliminated after 2 days, with higher efficiency achieved in the bioreactor than in flasks explained by glucose addition, pH management and air supplementation. In continuous mode, carbamazepine was reduced by 54% in the outflow compared to the inflow concentration of 200 μg/L. With Pleurotus ostreatus, another white-rot fungus, 68% carbamazepine was degraded in liquid culture after seven days with no further degradation after this time.

The filamentous fungus Trichoderma harzianum was able to degrade 72% of environmentally detected concentrations of carbamazepine (4 μg/L), which was superior compared to the polypore P. ostreatus. In a non-sterile bioreactor, Phanerochaete chrysosporium was able to degrade up to 80% of 5 mg/L carbamazepine when supplied with a diluted synthetic feed. In a fed-batch stirred bioreactor, P. chrysosporium removed yo to 60% carbamazepine (0.5 mg/L); however, it was unable to degrade diazepam (0.25–0.5 mg/L). In a fixed bed reactor, where the pellets of P. chrysoporium were immobilized in polyurethane, the remediation efficiency of carbamazepine and diazepam was significantly improved.

Even though nearly complete remediation of some beta-blockers and psychoactive drugs could be achieved in flask and lab bioreactor scale experiments, large or even pilot scale studies are needed to comprehensively evaluate the effect of upscaling on the remediation efficiency and the cost-effectiveness of using fungi for these drugs as an add-on treatment in WWTPs.

Non-steroidal Anti-inflammatory Drugs and Analgesics

Bioremediation using bacterial monocultures for the treatment of NSAIDs has not to date been successful. Some studies have shown the elimination of NSAIDs by bacterial consortia in WWTPs. One study showed that eliminating acetaminophen in an MBR was mainly associated with heterotrophic bacteria. They concluded that using a microbial consortium in an MBR could be complimentary for post-treating effluents from treatment plants containing pharmaceutical products. However, as seen with the consortia in CAS treatments, which are unidentified and often change in conjunction with the wastewater being treated, consortia in bioreactors may also change, resulting in decreased efficiency. To further explore the use of bacterial consortia in bioreactors, long-term studies need to be conducted on-site in WWTPs to evaluate the composition and stability of the bacterial assemblage, and it should be modeled how shifts could influence remediation.

In terms of mycoremediation, T. versicolor has shown very promising results in the remediation of NSAIDs. In a continuous MBR (with a hydraulic retention time of one day), T. versicolor eliminated 55% of diclofenac added at concentrations ranging from 0.3 to 1.5 mg/L. Another fungus that demonstrated the potential to degrade anti-inflammatory drugs is the edible fungus Lentinula edodes (shiitake mushroom). The degradation products of piroxicam produced by L. edodes degradation has already been described; however, the remediation percentage was not reported.

Penicillium oxalicum was capable of totally degrading diclofenac in 24 h, starting from an initial concentration of 29.6 mg/L (100 μM). For Mucor hiemalis f. irnsingii (DSM 14200; Zygomycota), a strain isolated from a groundwater source in Germany, the diclofenac (10–50 μg/L) removal percentages ranged between 90 and 97% after 6 days. The same micromycete was also employed for the remediation of acetaminophen. After 24 h of exposure to environmentally relevant concentrations of acetaminophen (up to 20 μg/L), M. hiemalis was able to degrade up to 50%. However, after 24 h, diclofenac remediation halted; nevertheless, pH maintenance could overcome this. The acetaminophen remediation efficiency of Phanerochaete chrysosporium (97 and 99% of 250 μg/L APAP after 3 and 7 days, respectively) was far superior to that of M. hiemalis, and co-cultivation of the two species resulted in a decreased remediation efficiency compared to P. chrysosporium in single.

Furthermore, studied the degradation of a mixture of acetaminophen, diclofenac, ibuprofen, ketoprofen and naproxen with P. oxalicum, starting from an initial concentration of 50 μM of each compound in both flasks and bench fluidized bioreactors. P. oxalicum showed higher degradation percentages in the bioreactor than at the flask scale. The authors reported that with glucose addition in the fluidized bed bioreactor, degradation of all drugs was complete after eight days.

In a fed-batch stirred bioreactor, P. chrysosporium oxidatively degraded up to 99% of diclofenac, ibuprofen, and naproxen each at a concentration of 0.8 mg/L. However, in continuously stirred bioreactors, P. chrysosporium degraded diclofenac, ibuprofen, and naproxen (1 mg/L each) up to 95%.

With these preliminary flask and laboratory-scale reactor experiments, the potential of using mycoremediation to treat NSAIDs is highlighted. However, data on the performance of the fungi in WWTPs is lacking, making a consequential evaluation impossible. A potential issue that may arise in practice is the need for maintenance and controlled conditions, as highlighted by the study conducted by, which showed the need for maintaining pH conditions.

To overcome the limitations of monocultures for the remediation of these pollutants, the use of microorganism-consortia has been explored. Consortia of microorganisms that complement each other could improve biological wastewater treatment technologies significantly. For example, found that a mixed bacterial culture in conjunction with T. versicolor in an augmented MBR better degraded PhACs than a system containing the fungus or bacteria alone. In addition, bioaugmentation technologies using adapted fungi, such as P. oxalicum, have proven an interesting technology to overcome the problem of competition with autochthonous microbiota, as demonstrated by. However, more data are needed to define complementary species since the study by revealed that co-culture of certain species could reduce the remediation efficiency.

Antibiotics

In general, low remediation efficiencies for most antibiotics from wastewaters have been reported using CAS treatment. Thus, CAS could be applied to treat some antibiotics; however, not all. More recently, increased antibiotic removal percentages have been reported with anoxic/anaerobic/oxic granular and suspended activated sludge processes, specifically with sulfamethoxazole. The shortcoming could be improved by supplementing the sludge with bacteria capable of better remediation or even mixing treatments and complementing CAS with mycoremediation with macromycetes has been proven to be very effective for antibiotics.

T. versicolor, in flask experiments, degraded the antibiotic ofloxacin (10 mg/L) with 80% efficiency. When upscaled to 10 L fluidized air-pulse bioreactors, ofloxacin spiked into hospital waste was removed by 98.5% under sterile conditions and 99% under nonsterile conditions.

reported the elimination of 55% clarithromycin (0.03 μg/L) by edible mushroom P. ostreatus and 57% by the micromycete T. harzianum. In flask experiments, P. ostreatus could also eliminate oxytetracycline (50 and 100 mg/L) after 14 days. The antifungal drugs bifonazole and clotrimazole were also bioaccumulated and eliminated by the mycelia of the edible fungus Lentinus edodes. In flask experiments, the cephalosporin antibiotic cefuroxime axetil was entirely eradicated by both the edible mushrooms Imleria badia and L. edodes within seven days at all concentrations tested (400, 1,000, 1,600 mg/L).

Leptosphaerulina sp. removed oxacillin (16 mg/L, in 6 days), cloxacillin (17.5 mg/L, in 7 days) and dicloxacillin (19 mg/L, in 8 days) from water in flask experiments by the action of laccase and peroxidase. With synthetic hospital waste, oxacillin was reduced by 60% within two days and wholly eradicated after six days by the Leptosphaerulina sp..

In a comparative study investigating the degradation efficiencies of five ligninolytic fungi, the polypore Irpex lacteus degraded the fluoroquinolone antibiotic flumequine, ciprofloxacin and ofloxacin effectively within six days. I. lacteus also removed the residual antibacterial activity of norfloxacin and ofloxacin via the action of manganese peroxidase.

evaluated fifty fungal isolates from sediments of salmon hatcheries for their oxytetracycline remediation abilities. The filamentous fungi Penicillium commune, Epicoccum nigrum, T. harzianum, Aspergillus terreus, and Beauveria bassiana were identified as having the best remediation rates amounting to a maximum of 78% removal of a 250 mg/L oxytetracycline concentration in flask experiments. P. oxalicum RJJ-2 has also been studied in the degradation of erythromycin and degraded 84.88% erythromycin after 96-h incubation used as the sole carbon source producing different metabolites.

The studies on the efficiency to remove antibiotics reported to date have focused on the efficiency under set conditions. However, in a WWTP, environmental conditions and even the water’s parameter would fluctuate from time to time. How this could affect the remediation efficiency and fungal longevity over time is unknown. Nevertheless, this information could be essential in evaluating this technique’s applicability in the field. It is importante to note the relevance of the use of fungi in removing antibiotics since bacteria can adquire rapidly antibiotic resistance genes during bioremediation and contribute to the widespread of ARGs.

Endocrine Disruptors

The fate of estrogenic hormones treated via activated sludge systems in full-scale WWTPs was reviewed by. Activated sludge systems with nutrient removal achieved more than 90% degradation in most studies.

Degradation of testosterone and 17α-ethinylestradiol (EE2) by the fungus L. edodes was reported by, with no testosterone or 17α-ethynylestradiol detected after 21 days. Interestingly, the white-rot fungus P. ostreatus HK 35, in the presence of the natural water microbiota of a WWTP, degraded up to 90% of 17β-estradiol (E2) within 12 days in various bioreactor sizes and under different regimes. The micromycete Trichoderma citrinoviride AJAC3 degraded 99.6% 17 β-estradiol (E2) (at a starting concentration of 200 mg/L) after four days attributed to the secretion of ligninolytic enzymes. A study investigating the efficiency of mycoremediation to remove 17 β-estradiol (E2) from poultry litter found that the polypore Pycnoporus sp. SYBC-L3 could remove up to 78.4% via solid-state cultivation supplemented with citric acid and lignocellulosic biomasses to boost laccase activity, an approach that could be tested for increasing remediation from wastewaters.

Even though the hormone remediation percentage reported with mycoremediation is, in some cases, higher than the CAS studies reviewed by, a comparison is not possible since the studies on the fungal efficiency were performed in the laboratory in comparison to the CAS studies completed on-site at WWTPs. In addition to excluding several variables that could impact the remediation efficiency, these studies have established the remediation efficiencies for individual compounds. In wastewater effluent, a mixture of not only PhACs are present, and the synergistic effect of all these compounds could affect the efficiencies reported.

Bioabsorption is another approach to PhAC remediation with fungi. L. edodes and Agaricus bisporus (champignon) stalks removal 100% of 17α-ethinylestradiol (EE2) in 20 and 30 min, respectively via absorption, whereas Shiitake substrate absorbed 80%.

Despite the high hormone remediation percentages achieved with fungi described above, few studies have been published on this topic in the last decade, and renewed investigations would greatly benefit the development of this technique to elevate the environmental impacts of hormones released untreated from WWTPs.

Mixed Effluents

studied the degradation of pharmaceuticals in hospital effluent by T. versicolor. By employing fluidized bed bioreactor in fed-batch mode, T. versicolor could eliminate ibuprofen (2.34 mg/L), acetaminophen (1.56 mg/L), ketoprofen (0.08 mg/L), propranolol (0.06 mg/L), and azithromycin (4.31 mg/L). By running the fluidized bed reactor in continuous mode, the efficiency was increased, and the fungus was able to completely remove acetaminophen (109 mg/L), naproxen (1.62 mg/L), ibuprofen (35.5 mg/L), diclofenac (0.477 mg/L), codeine (0.606 mg/L), trimethoprim (0.853 mg/L), and sulfamethoxazole 1.41 mg/L 100%, and partially remove several other drugs. However, salicylic acid, tetracycline, and carbamazepine were not degraded. T. versicolor was also investigated for its performance to remediate PhACs from veterinary hospital wastewater; however, only 66% removal efficiency was achieved in a non-sterile batch bioreactor.

P. oxalicum XD.3.1 has also been used in batch bench-scale bioreactors to test the remediation efficiency with real hospital effluents. Within 24 h, P. oxalicum was able to reduce the majority of the PhAC present in the effluent, including ketoprofen, naproxen and paracetamol. Interestingly, P. oxalicum also affected the native microbiota, including opportunistic pathogens. In fluidized bed bioreactor studies, including hospital wastewater spiked with 10 mg/L each diclofenac, ketoprofen, and atenolol, P. ostreatus completely remediated diclofenac in 24 h and 50% of the ketoprofen in 5 days. However, atenolol was not removed. These studies demonstrated the complexity of degrading PhAC in mixed matrix effluents, which could drastically reduce the remediation efficiency. Therefore, more studies should be conducted at a larger scale employing real effluents to develop mycoremediation using fungi.

Currently, mycoremediation studies on other emerging PhACs, such as anticancer and antiretrovirals, are lacking. Testing fungal species capable of degrading pharmaceuticals at a laboratory scale is ongoing; however, it is difficult to predict how biological organisms would cope in a treatment facility exposed to chemical mixtures over long periods. Thus, recognizing the potential of mycoremediation for the treatment of pharmaceuticals demonstrated to date, studies regarding functioning and long-term applicability in practical terms to evaluate the feasibility of mycoremediation fully are still lacking. However, limitations such as partial degradation of pharmaceuticals and reduced efficiency at lower PhAC concentrations have been identified but could be overcome by using consortia or optimizing enzyme extraction and isolation to reduce costs.

The exact mechanism of degradation for each fungal type and PhACs is still vague due to its complexity and all the counterparts involved. However, the degradation seems to include activities of the intracellular enzymatic system such as the cytochrome P450 system, mainly in fungi lacking ligninolityc enzymes, and the extracellular enzymatic system, including lignin peroxidase, manganese peroxidase, laccase, versatile peroxidase as well as hydroxyl and free radical, in the case of lignin degrading enzymes producers. Nevertheless, elimination is reported to produce no toxic byproducts, therefore necessitating further studies into mycoremediation optimization for an add-on in WWTPs and elucidating the mechanism of action.

Isolated Fungal Enzymes

The use of isolated fungal enzymes could also overcome some limitations associated with mycoremediation. Fungal enzymes, specifically the ligninolytic enzymes, have been recognized for their abilities to transform a broad range of recalcitrant PhACs. However, difficulties in growing fungi on a large scale, together with the long incubation processes, extensive growth phase, and spore formation, have prompted the exploration of extracted crude and isolated enzymes. Though, to date, the main limiting factor has been the high cost of the enzyme purification procedure.

Commercially available laccases from T. versicolor efficiently degraded diclofenac, trimethoprim, carbamazepine and sulfamethoxazole as individual drugs, but the remediation efficiency decreased when applied to mixtures of the drugs. isolated laccases from Bjerkandera spp., which could efficiently remediate acetaminophen under a range of pH conditions. In a study employing immobilized laccases from Trametes hirsuta, reported better remediation efficiencies for carbamazepine and acetaminophen (40 and 70%) in single compared to in mixtures (5 and 25%).

Using laccases (2,000 U/L) isolated from Myceliophthora thermophile, 94.1 and 95.5% of estrone E1 and 17β-estradiol E2 could be degraded within 8 h in the presence of a natural mediator in a fed-batch bioreactor. In an enzymatic membrane reactor (EMR) with a stir-tank configuration, this percentage was increased to 95% for E1 and near total E2 degradation. This indicates that the bioreactor type significantly impacts the remediation efficiency regarding isolated enzymes. In a study by, immobilized laccase from T. versicolor and M. thermophila could degrade 83 and 87%, respectively, of estrogenic compounds (E1 estrone; E2 17β-estradiol; EE2 17α-ethinylestradiol) in mixtures with other endocrine-disrupting compounds within 6h. reported 96.5% remediation of 10 mg/L 17-α-ethinylestradiol by Pycnoporus sanguineus laccase (1,642 U/mL) after 8 h. It would be noted that 1% (v/w) was added to the fungal culture to promote optimal laccase production concentration before extraction.

Utilizing isolated enzymes has the advantages of reducing the remediation time by avoiding the lag phase of fungal growth, reducing sludge production, and facilitating process control. Apart from the high cost as a disadvantage, a study by demonstrated another drawback of using isolated enzymes. In a direct comparison, whole-cell culture degraded trace organic compounds with higher efficiency, which is said to be facilitated by biosorption and the activity of both intracellular and mycelium associated enzymes.

Conclusion

The environmental impact of pharmaceuticals and their proper elimination from wastewaters have gained interest in recent years, mostly due to the intrinsic characteristics of these compounds, their massive use, and the negative effects on the environment and humans. Although they are medicinal substances developed to aid in the well-being of organisms, their indiscriminate use can lead to irreversible environmental problems. Therefore, it is important to create legislation according to the current standards of using substances and eco-friendly trends. More versatile and efficient systems for eliminating PhACs such as mycoremediation are being developed to lessen or avoid the problems associated with pharmaceutical pollution in the environment. However, these promising techniques are still at a laboratory scale and data regarding the application in WWTPs are still lacking. Even though new techniques for the remediation of PhAC are being developed and optimized, relative to the development of new drugs, implementing these techniques into practice is slow. New promising approaches for this purpose, such as genetic engineering, are still in their infancy. Thus, the new editing tool, such as CRISPR-Cas9, could help to introduce metabolic genes focused on target recalcitrant compounds. Much more studies are still necessary to deal with the problem of PhACs.

Author Contributions

ME, EA, DRO-H: conceptualization. MO and ME: literature search and data analysis and original draft preparation. MO, ME, DRO-H, JG-L, and EA: critical revision of the work. All authors contributed to the article and approved the submitted version.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References 286

  1. 1.

    Abafe O. A. Späth J. Fick J. Jansson S. Buckley C. Stark A. (2018 ). LC-MS/MS determination of antiretroviral drugs in influents and effluents from wastewater treatment plants in KwaZulu-Natal, South Africa. Chemosphere 200 660–670.

    Not in our library10.1016/j.chemosphere.2018.02.105

  2. 2.

    Agunbiade F. O. Moodley B. (2016 ). Occurrence and distribution pattern of acidic pharmaceuticals in surface water, wastewater, and sediment of the Msunduzi River, Kwazulu-Natal, South Africa. Environ. Toxicol. Chem. 35, 36–46.

    Not in our library10.1002/etc.3144

  3. 3.

    Ahmed I. Iqbal H. M. N. Dhama K. (2017 ). Enzyme-based biodegradation of hazardous pollutants—An overview. J. Exp. Biol. Agric. Sci. 5 402–411.

    Not in our library10.18006/2017.5(4).402.411

  4. 4.

    Ahumada-Rudolph R. Novoa V. Becerra J. Cespedes C. Cabrera-Pardo J. R. (2021 ). Mycoremediation of oxytetracycline by marine fungi mycelium isolated from salmon farming areas in the south of Chile. Food Chem. Toxicol. 152:112198.

    Not in our library10.1016/j.fct.2021.112198

  5. 5.

    Akhbarizadeh R. Russo G. Rossi S. Golianova K. Moore F. Guida M. (2021 ). Emerging endocrine disruptors in two edible fish from the Persian Gulf: occurrence, congener profile, and human health risk assessment. Mar. Pollut. Bull. 166:112241.

    Not in our library10.1016/j.marpolbul.2021.112241

  6. 6.

    Akhtar N. Mannan M. A. (2020 ). Mycoremediation: expunging environmental pollutants. Biotechnol. Rep. 26:e00452.

    Not in our library10.1016/j.btre.2020.e00452

  7. 7.

    Alharbi S. K. Nghiem L. D. van de Merwe J. P. Leusch F. D. L. Asif M. B. Hai F. I. (2019 ). Degradation of diclofenac, trimethoprim, carbamazepine, and sulfamethoxazole by laccase from Trametes versicolor: transformation products and toxicity of treated effluent. Biocatal. Biotransformation 37 399–408.

    Not in our library10.1080/10242422.2019.1580268

  8. 8.

    Ali A. M. Rønning H. T. Alarif W. Kallenborn R. Al-Lihaibi S. S. (2017 ). Occurrence of pharmaceuticals and personal care products in effluent-dominated Saudi Arabian coastal waters of the Red Sea. Chemosphere 175 505–513.

    Not in our library10.1016/j.chemosphere.2017.02.095

  9. 9.

    Aminot Y. Litrico X. Chambolle M. Arnaud C. Pardon P. Budzindki H. (2015 ). Development and application of a multi-residue method for the determination of 53 pharmaceuticals in water, sediment, and suspended solids using liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 407, 8585–8604.

    Not in our library10.1007/s00216-015-9017-3

  10. 10.

    Amos G. C. A. Ploumakis S. Zhang L. Hawkey P. M. Gaze W. H. Wellington E. M. H. (2018 ). The widespread dissemination of integrons throughout bacterial communities in a riverine system. ISME J. 12 681–691.

    Not in our library10.1038/s41396-017-0030-8

  11. 11.

    Andrade-Eiroa A. Canle M. Leroy-Cancellieri V. Cerdà V. (2016 ). Solid-phase extraction of organic compounds: a critical review (Part I). TrAC Trends Anal. Chem. 80 641–654.

    Not in our library10.1016/j.trac.2015.08.015

  12. 12.

    Ashe B. Nguyen L. N. Hai F. I. Lee D.-J. van de Merwe J. P. Leusch F. D. L. (2016 ). Impacts of redox-mediator type on trace organic contaminants degradation by laccase: degradation efficiency, laccase stability and effluent toxicity. Int. Biodeterior. Biodegradation 113 169–176.

    Not in our library10.1016/j.ibiod.2016.04.027

  13. 13.

    Ashton D. Hilton M. Thomas K. V. (2004 ). Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci. Total Environ. 333, 167–184.

    Not in our library10.1016/j.scitotenv.2004.04.062

  14. 14.

    Asif M. B. Hai F. I. Singh L. Price W. E. Nghiem L. D. (2017 ). Degradation of pharmaceuticals and personal care products by white-rot fungi—a critical review. Curr. Pollut. Rep. 3 88–103.

    Not in our library10.1007/s40726-017-0049-5

  15. 15.

    aus der Beek T. Weber F.-A. Bergmann A. Hickmann S. Ebert I. Hein A. (2016 ). Pharmaceuticals in the environment—global occurrences and perspectives. Environ. Toxicol. Chem. 35 823–835.

    Not in our library10.1002/etc.3339

  16. 16.

    Azanu D. Styrishave B. Darko G. Weisser J. J. Abaidoo R. C. (2018 ). Occurrence and risk assessment of antibiotics in water and lettuce in Ghana. Sci. Total Environ. 622–623, 293–305.

    Not in our library10.1016/j.scitotenv.2017.11.287

  17. 17.
    Bioremediation techniques–classification based on site of application: principles, advantages, limitations and prospects · 2016
    No notice
  18. 18.

    Azuma T. Otomo K. Kunitou M. Shimizu M. Hosomaru K. Mikata S. (2019 ). Environmental fate of pharmaceutical compounds and antimicrobial-resistant bacteria in hospital effluents, and contributions to pollutant loads in the surface waters in Japan. Sci. Total Environ. 657, 476–484.

    Not in our library10.1016/j.scitotenv.2018.11.433

  19. 19.

    Badia-Fabregat M. Lucas D. Pereira M. A. Alves M. Pennanen T. Fritze H. (2016 ). Continuous fungal treatment of non-sterile veterinary hospital effluent: pharmaceuticals removal and microbial community assessment. Appl. Microbiol. Biotechnol. 100 2401–2415.

    Not in our library10.1007/s00253-015-7105-0

  20. 20.

    Balakrishna K. Rath A. Praveenkumarreddy Y. Guruge K. S. Subedi B. (2017 ). A review of the occurrence of pharmaceuticals and personal care products in Indian water bodies. Ecotoxicol. Environ. Saf. 137 113–120.

    Not in our library10.1016/j.ecoenv.2016.11.014

  21. 21.

    Barber L. B. Loyo-Rosales J. E. Rice C. P. Minarik T. A. Oskouie A. K. (2015 ). Endocrine disrupting alkylphenolic chemicals and other contaminants in wastewater treatment plant effluents, urban streams, and fish in the Great Lakes and Upper Mississippi River Regions. Sci. Total Environ. 517 195–206.

    Not in our library10.1016/j.scitotenv.2015.02.035

  22. 22.

    Barh A. Kumari B. Sharma S. Annepu S. K. Kumar A. Kamal S. (2019 ). “Chapter 1 - mushroom mycoremediation: kinetics and mechanism,” in Smart Bioremediation Technologies, ed. Bhatt P. (Cambridge, MA: Academic Press), 1–22.

    Not in our library10.1016/b978-0-12-818307-6.00001-9

  23. 23.

    Barrios-Estrada C. de Jesús Rostro-Alanis M. Muñoz-Gutiérrez B. D. Iqbal H. M. N. Kannan S. Parra-Saldívar R. (2018 ). Emergent contaminants: endocrine disruptors and their laccase-assisted degradation – a review. Sci. Total Environ. 612 1516–1531.

    Not in our library10.1016/j.scitotenv.2017.09.013

  24. 24.

    Bártíková H. Podlipná R. Skálová L. (2016 ). Veterinary drugs in the environment and their toxicity to plants. Chemosphere 144 2290–2301.

    Not in our library10.1016/j.chemosphere.2015.10.137

  25. 25.

    Bartolo N. S. Azzopardi L. M. Serracino-Inglott A. (2021 ). Pharmaceuticals and the environment. Early Hum. Dev. 155:105218.

    Not in our library10.1016/j.earlhumdev.2020.105218

  26. 26.

    Becker D. Rodriguez-Mozaz S. Insa S. Schoevaart R. Barceló D. de Cazes M. (2017 ). Removal of endocrine disrupting chemicals in wastewater by enzymatic treatment with fungal laccases. Org. Process Res. Dev. 21 480–491.

    Not in our library10.1021/acs.oprd.6b00361

  27. 27.

    Ben Maamar M. Lesné L. Hennig K. Desdoits-Lethimonier C. Kilcoyne K. R. Coiffec I. (2017 ). Ibuprofen results in alterations of human fetal testis development. Sci. Rep. 7:44184.

    Not in our library10.1038/srep44184

  28. 28.

    Bengtsson-Palme J. Larsson D. G. J. (2016 ). Concentrations of antibiotics predicted to select for resistant bacteria: proposed limits for environmental regulation. Environ. Int. 86 140–149.

    Not in our library10.1016/j.envint.2015.10.015

  29. 29.

    Bernabeu-Martínez M. A. Ramos Merino M. Santos Gago J. M. Álvarez Sabucedo L. M. Wanden-Berghe C. Sanz-Valero J. (2018 ). Guidelines for safe handling of hazardous drugs: a systematic review. PLoS One 13:e0197172.

    Not in our library10.1371/journal.pone.0197172

  30. 30.

    Bilal M. Mehmood S. Rasheed T. Iqbal H. M. N. (2020 ). Antibiotics traces in the aquatic environment: persistence and adverse environmental impact. Curr. Opin. Environ. Sci. Heal. 13 68–74.

    Not in our library10.1016/j.coesh.2019.11.005

  31. 31.

    Bis M. Montusiewicz A. Piotrowicz A. Łagód G. (2019 ). Modeling of wastewater treatment processes in membrane bioreactors compared to conventional activated sludge systems. Processes 7:285.

    Not in our library10.3390/pr7050285

  32. 32.

    Bittner L. Teixido E. Seiwert B. Escher B. I. Klüver N. (2018 ). Influence of pH on the uptake and toxicity of β-blockers in embryos of zebrafish, Danio rerio. Aquat. Toxicol. 201 129–137.

    Not in our library10.1016/j.aquatox.2018.05.020

  33. 33.

    Blanco G. Junza A. Barrón D. (2017 ). Occurrence of veterinary pharmaceuticals in golden eagle nestlings: unnoticed scavenging on livestock carcasses and other potential exposure routes. Sci. Total Environ. 586 355–361.

    Not in our library10.1016/j.scitotenv.2017.02.023

  34. 34.

    Bondarczuk K. Piotrowska-Seget Z. (2019 ). Microbial diversity and antibiotic resistance in a final effluent-receiving lake. Sci. Total Environ. 650 2951–2961.

    Not in our library10.1016/j.scitotenv.2018.10.050

  35. 35.

    Borecka M. Siedlewicz G. Haliński Ł. P. Sikora K. Pazdro K. Stepnowski P. (2015 ). Contamination of the southern Baltic Sea waters by the residues of selected pharmaceuticals: method development and field studies. Mar. Pollut. Bull. 94, 62–71.

    Not in our library10.1016/j.marpolbul.2015.03.008

  36. 36.

    Borgeat A. Ofner C. Saporito A. Farshad M. Aguirre J. (2018 ). The effect of nonsteroidal anti-inflammatory drugs on bone healing in humans: a qualitative, systematic review. J. Clin. Anesth. 49 92–100.

    Not in our library10.1016/j.jclinane.2018.06.020

  37. 37.

    Boulard L. Dierkes G. Ternes T. (2018 ). Utilization of large volume zwitterionic hydrophilic interaction liquid chromatography for the analysis of polar pharmaceuticals in aqueous environmental samples: benefits and limitations. J. Chromatogr. A 1535, 27–43.

    Not in our library10.1016/j.chroma.2017.12.023

  38. 38.

    Braeuer S. Borovička J. Kameník J. Prall E. Stijve T. Goessler W. (2020 ). Is arsenic responsible for the toxicity of the hyperaccumulating mushroom Sarcosphaera coronaria? Sci. Total Environ. 736:139524.

    Not in our library10.1016/j.scitotenv.2020.139524

  39. 39.

    Brain R. A. Hanson M. L. Solomon K. R. Brooks B. W. (2008 ). Aquatic plants exposed to pharmaceuticals: effects and risks. Rev. Environ. Contam. Toxicol. 192 67–115.

    Not in our library10.1007/978-0-387-71724-1_3

  40. 40.

    Branchet P. Ariza Castro N. Fenet H. Gomez E. Courant F. Sebag D. (2019 ). Anthropic impacts on Sub-Saharan urban water resources through their pharmaceutical contamination (Yaoundé, Center Region, Cameroon). Sci. Total Environ. 660, 886–898.

    Not in our library10.1016/j.scitotenv.2018.12.256

  41. 41.

    Braun J. M. (2017 ). Early-life exposure to EDCs: role in childhood obesity and neurodevelopment. Nat. Rev. Endocrinol. 13 161–173.

    Not in our library10.1038/nrendo.2016.186

  42. 42.

    Brausch J. M. Connors K. A. Brooks B. W. Rand G. M. (2012 ). Human pharmaceuticals in the aquatic environment: a review of recent toxicological studies and considerations for toxicity testing. Rev. Environ. Contam. Toxicol. 218 1–99.

    Not in our library10.1007/978-1-4614-3137-4_1

  43. 43.

    Brown K. D. Kulis J. Thomson B. Chapman T. H. Mawhinney D. B. (2006 ). Occurrence of antibiotics in hospital, residential, and dairy effluent, municipal wastewater, and the Rio Grande in New Mexico. Sci. Total Environ. 366 772–783.

    Not in our library10.1016/j.scitotenv.2005.10.007

  44. 44.

    Buchicchio A. Bianco G. Sofo A. Masi S. Caniani D. (2016 ). Biodegradation of carbamazepine and clarithromycin by Trichoderma harzianum and Pleurotus ostreatus investigated by liquid chromatography – high-resolution tandem mass spectrometry (FTICR MS-IRMPD). Sci. Total Environ. 55 733–739.

    Not in our library10.1016/j.scitotenv.2016.03.119

  45. 45.

    Buelow E. Bayjanov J. R. Majoor E. Willems R. J. L. Bonten M. J. M. Schmitt H. (2018 ). Limited influence of hospital wastewater on the microbiome and resistome of wastewater in a community sewerage system. FEMS Microbiol. Ecol. 94:fiy087.

    Not in our library10.1093/femsec/fiy087

  46. 46.

    Cacace D. Fatta-Kassinos D. Manaia C. M. Cytryn E. Kreuzinger N. Rizzo L. (2019 ). Antibiotic resistance genes in treated wastewater and in the receiving water bodies: a pan-European survey of urban settings. Water Res. 162 320–330.

    Not in our library10.1016/j.watres.2019.06.039

  47. 47.

    Cardoso O. Porcher J.-M. Sanchez W. (2014 ). Factory-discharged pharmaceuticals could be a relevant source of aquatic environment contamination: review of evidence and need for knowledge. Chemosphere 115 20–30.

    Not in our library10.1016/j.chemosphere.2014.02.004

  48. 48.

    Carvalho I. T. Santos L. (2016 ). Antibiotics in the aquatic environments: a review of the European scenario. Environ. Int. 94 736–757.

    Not in our library10.1016/j.envint.2016.06.025

  49. 49.

    Chari R. V. J. (2008 ). Targeted cancer therapy: conferring specificity to cytotoxic drugs. Acc. Chem. Res. 41 98–107.

    Not in our library10.1021/ar700108g

  50. 50.

    Chatterjee A. Abraham J. (2019 ). Mycoremediation of 17 β-Estradiol using Trichoderma citrinoviride strain AJAC3 along with enzyme studies. Environ. Prog. Sustain. Energy 38:13142.

    Not in our library10.1002/ep.13142

  51. 51.

    Chaturvedi P. Giri B. S. Shukla P. Gupta P. (2021a ). Recent advancement in remediation of synthetic organic antibiotics from environmental matrices: challenges and perspective. Bioresour. Technol. 319:124161.

    Not in our library10.1016/j.biortech.2020.124161

  52. 52.

    Chaturvedi P. Shukla P. Giri B. S. Chowdhary P. Chandra R. Gupta P. (2021b ). Prevalence and hazardous impact of pharmaceutical and personal care products and antibiotics in environment: a review on emerging contaminants. Environ. Res. 194:110664.

    Not in our library10.1016/j.envres.2020.110664

  53. 53.

    Clara M. Strenn B. Gans O. Martinez E. Kreuzinger N. Kroiss H. (2005 ). Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res. 39, 4797–4807.

    Not in our library10.1016/j.watres.2005.09.015

  54. 54.

    Coleman M. D. (2020 ). Human Drug Metabolism. Hoboken, NJ: John Wiley & Sons.

    Not in our library

  55. 55.

    Comber S. Gardner M. Sörme P. Leverett D. Ellor B. (2018 ). Active pharmaceutical ingredients entering the aquatic environment from wastewater treatment works: a cause for concern? Sci. Total Environ. 613–614 538–547.

    Not in our library10.1016/j.scitotenv.2017.09.101

  56. 56.

    Copete-Pertuz L. S. Plácido J. Serna-Galvis E. A. Torres-Palma R. A. Mora A. (2018 ). Elimination of isoxazolyl-penicillins antibiotics in waters by the ligninolytic native colombian strain Leptosphaerulina sp. considerations on biodegradation process and antimicrobial activity removal. Sci. Total Environ. 630 1195–1204.

    Not in our library10.1016/j.scitotenv.2018.02.244

  57. 57.

    Courtheyn D. Le Bizec B. Brambilla G. De Brabander H. F. Cobbaert E. Van de Wiele M. (2002 ). Recent developments in the use and abuse of growth promoters. Anal. Chim. Acta 473 71–82.

    Not in our library10.1016/s0003-2670(02)00753-5

  58. 58.

    Crini G. Lichtfouse E. (2019 ). Advantages and disadvantages of techniques used for wastewater treatment. Environ. Chem. Lett. 17 145–155.

    Not in our library10.1007/s10311-018-0785-9

  59. 59.

    Cristóvão M. B. Bento-Silva A. Bronze M. R. Crespo J. G. Pereira V. J. (2021 ). Detection of anticancer drugs in wastewater effluents: grab versus passive sampling. Sci. Total Environ. 786:147477.

    Not in our library10.1016/j.scitotenv.2021.147477

  60. 60.

    Cristóvão M. B. Torrejais J. Janssens R. Luis P. Van der Bruggen B. Dubey K. K. (2019 ). Treatment of anticancer drugs in hospital and wastewater effluents using nanofiltration. Sep. Purif. Technol. 224 273–280.

    Not in our library10.1016/j.seppur.2019.05.016

  61. 61.

    Cruz-Morató C. Ferrando-Climent L. Rodriguez-Mozaz S. Barceló D. Marco-Urrea E. Vicent T. (2013 ). Degradation of pharmaceuticals in non-sterile urban wastewater by Trametes versicolor in a fluidized bed bioreactor. Water Res. 47 5200–5210.

    Not in our library10.1016/j.watres.2013.06.007

  62. 62.

    Cruz-Morató C. Lucas D. Llorca M. Rodriguez-Mozaz S. Gorga M. Petrovic M. (2014 ). Hospital wastewater treatment by fungal bioreactor: removal efficiency for pharmaceuticals and endocrine disruptor compounds. Sci. Total Environ. 493 365–376.

    Not in our library10.1016/j.scitotenv.2014.05.117

  63. 63.

    Cuthbert R. Parry-Jones J. Green R. E. Pain D. J. (2007 ). NSAIDs and scavenging birds: potential impacts beyond Asia’s critically endangered vultures. Biol. Lett. 3 91–94.

    Not in our library10.1098/rsbl.2006.0554

  64. 64.

    Čvanv̌arová M. Moeder M. Filipová A. Cajthaml T. (2015 ). Biotransformation of fluoroquinolone antibiotics by ligninolytic fungi – metabolites, enzymes and residual antibacterial activity. Chemosphere 136 311–320.

    Not in our library10.1016/j.chemosphere.2014.12.012

  65. 65.

    Èvanèarová M. Moeder M. Filipová A. Reemtsma T. Cajthaml T. (2013 ). Biotransformation of the antibiotic agent flumequine by ligninolytic fungi and residual antibacterial activity of the transformation mixtures. Environ. Sci. Technol. 47 14128–14136.

    Not in our library10.1021/es403470s

  66. 66.

    Dąbrowska M. Muszyńska B. Starek M. Żmudzki P. Opoka W. (2018 ). Degradation pathway of cephalosporin antibiotics by in vitro cultures of Lentinula edodes and Imleria badia. Int. Biodeterior. Biodegrad. 127 104–112.

    Not in our library10.1016/j.ibiod.2017.11.014

  67. 67.

    Danner M.-C. Robertson A. Behrends V. Reiss J. (2019 ). Antibiotic pollution in surface fresh waters: occurrence and effects. Sci. Total Environ. 664 793–804.

    Not in our library10.1016/j.scitotenv.2019.01.406

  68. 68.

    Daouk S. Chèvre N. Vernaz N. Bonnabry P. Dayer P. Daali Y. (2015 ). Prioritization methodology for the monitoring of active pharmaceutical ingredients in hospital effluents. J. Environ. Manage. 160 324–332.

    Not in our library10.1016/j.jenvman.2015.06.037

  69. 69.

    David A. Pancharatna K. (2009 ). Developmental anomalies induced by a non-selective COX inhibitor (ibuprofen) in zebrafish (Danio rerio). Environ. Toxicol. Pharmacol. 27 390–395.

    Not in our library10.1016/j.etap.2009.01.002

  70. 70.

    De Gusseme B. Vanhaecke L. Verstraete W. Boon N. (2011 ). Degradation of acetaminophen by Delftia tsuruhatensis and Pseudomonas aeruginosa in a membrane bioreactor. Water Res. 45 1829–1837.

    Not in our library10.1016/j.watres.2010.11.040

  71. 71.

    Deo R. P. (2014 ). Pharmaceuticals in the surface water of the USA: a review. Curr. Environ. Heal. Rep. 1 113–122.

    Not in our library10.1007/s40572-014-0015-y

  72. 72.

    Dhangar K. Kumar M. (2020 ). Tricks and tracks in removal of emerging contaminants from the wastewater through hybrid treatment systems: a review. Sci. Total Environ. 738:140320.

    Not in our library10.1016/j.scitotenv.2020.140320

  73. 73.

    Domaradzka D. Guzik U. Wojcieszyńska D. (2015 ). Biodegradation and biotransformation of polycyclic non-steroidal anti-inflammatory drugs. Rev. Environ. Sci. Biotechnol. 14 229–239.

    Not in our library10.1007/s11157-015-9364-8

  74. 74.
    Occurrence, seasonal variation and human exposure to pharmaceuticals and personal care products in surface water, groundwater and drinking water in Lagos State, Nigeria · 2020
    Not checked
  75. 75.

    Edwards S. J. Kjellerup B. V. (2013 ). Applications of biofilms in bioremediation and biotransformation of persistent organic pollutants, pharmaceuticals/personal care products, and heavy metals. Appl. Microbiol. Biotechnol. 97 9909–9921.

    Not in our library10.1007/s00253-013-5216-z

  76. 76.

    Ekpeghere K. I. Lee J.-W. Kim H.-Y. Shin S.-K. Oh J.-E. (2017 ). Determination and characterization of pharmaceuticals in sludge from municipal and livestock wastewater treatment plants. Chemosphere 168 1211–1221.

    Not in our library10.1016/j.chemosphere.2016.10.077

  77. 77.

    Ekpeghere K. I. Sim W.-J. Lee H.-J. Oh J.-E. (2018 ). Occurrence and distribution of carbamazepine, nicotine, estrogenic compounds, and their transformation products in wastewater from various treatment plants and the aquatic environment. Sci. Total Environ. 640–641 1015–1023.

    Not in our library10.1016/j.scitotenv.2018.05.218

  78. 78.

    Esterhuizen-Londt M. Hendel A.-L. Pflugmacher S. (2017 ). Mycoremediation of diclofenac using Mucor hiemalis. Toxicol. Environ. Chem. 99 795–808.

    Not in our library10.1080/02772248.2017.1296444

  79. 79.

    Esterhuizen-Londt M. Schwartz K. Balsano E. Kühn S. Pflugmacher S. (2016a ). LC–MS/MS method development for quantitative analysis of acetaminophen uptake by the aquatic fungus Mucor hiemalis. Ecotoxicol. Environ. Saf. 128 230–235.

    Not in our library10.1016/j.ecoenv.2016.02.029

  80. 80.

    Esterhuizen-Londt M. Schwartz K. Pflugmacher S. (2016b ). Using aquatic fungi for pharmaceutical bioremediation: uptake of acetaminophen by Mucor hiemalis does not result in an enzymatic oxidative stress response. Fungal Biol. 120 1249–1257.

    Not in our library10.1016/j.funbio.2016.07.009

  81. 81.

    Esterhuizen M. Behnam Sani S. Wang L. Kim Y. J. Pflugmacher S. (2021 ). Mycoremediation of acetaminophen: culture parameter optimization to improve efficacy. Chemosphere 263:128117.

    Not in our library10.1016/j.chemosphere.2020.128117

  82. 82.

    Fang T.-H. Nan F.-H. Chin T.-S. Feng H.-M. (2012 ). The occurrence and distribution of pharmaceutical compounds in the effluents of a major sewage treatment plant in Northern Taiwan and the receiving coastal waters. Mar. Pollut. Bull. 64, 1435–1444.

    Not in our library10.1016/j.marpolbul.2012.04.008

  83. 83.

    Fekadu S. Alemayehu E. Dewil R. Van der Bruggen B. (2019 ). Pharmaceuticals in freshwater aquatic environments: a comparison of the African and European challenge. Sci. Total Environ. 654 324–337.

    Not in our library10.1016/j.scitotenv.2018.11.072

  84. 84.

    Ferlay J. Steliarova-Foucher E. Lortet-Tieulent J. Rosso S. Coebergh J. W. W. Comber H. (2013 ). Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur. J. Cancer 49 1374–1403.

    Not in our library10.1016/j.ejca.2012.12.027

  85. 85.

    Ferrari B. Mons R. Vollat B. Fraysse B. Paxēaus N. Lo G. R. (2004 ). Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment? Environ. Toxicol. Chem. 23 1344–1354.

    Not in our library10.1897/03-246

  86. 86.

    Ferreira T. C. R. Esterhuizen-Londt M. Zaiat M. Pflugmacher S. (2018 ). Fate of enrofloxacin in lake sediment: biodegradation, transformation product identification, and ecotoxicological implications. Soil Sediment Contam. Int. J. 27 357–368.

    Not in our library10.1080/15320383.2018.1478798

  87. 87.

    Fisher I. J. Phillips P. J. Colella K. M. Fisher S. C. Tagliaferri T. Foreman W. T. (2016 ). The impact of onsite wastewater disposal systems on groundwater in areas inundated by Hurricane Sandy in New York and New Jersey. Mar. Pollut. Bull. 107, 509–517.

    Not in our library10.1016/j.marpolbul.2016.04.038

  88. 88.

    Flippin J. L. Huggett D. Foran C. M. (2007 ). Changes in the timing of reproduction following chronic exposure to ibuprofen in Japanese medaka, Oryzias latipes. Aquat. Toxicol. 81 73–78.

    Not in our library10.1016/j.aquatox.2006.11.002

  89. 89.

    Fonseca V. F. Duarte I. A. Duarte B. Freitas A. Pouca A. S. V. Barbosa J. (2021 ). Environmental risk assessment and bioaccumulation of pharmaceuticals in a large urbanized estuary. Sci. Total Environ. 783:147021.

    Not in our library10.1016/j.scitotenv.2021.147021

  90. 90.

    Forte M. Di Lorenzo M. Carrizzo A. Valiante S. Vecchione C. Laforgia V. (2016 ). Nonylphenol effects on human prostate non tumorigenic cells. Toxicology 357–358 21–32.

    Not in our library10.1016/j.tox.2016.05.024

  91. 91.

    Forte M. Di Lorenzo M. Iachetta G. Mita D. G. Laforgia V. De Falco M. (2019 ). Nonylphenol acts on prostate adenocarcinoma cells via estrogen molecular pathways. Ecotoxicol. Environ. Saf. 180 412–419.

    Not in our library10.1016/j.ecoenv.2019.05.035

  92. 92.

    Freeman C. N. Scriver L. Neudorf K. D. Truelstrup Hansen L. Jamieson R. C. Yost C. K. (2018 ). Antimicrobial resistance gene surveillance in the receiving waters of an upgraded wastewater treatment plant. FACETS 3 128–138.

    Not in our library10.1139/facets-2017-0085

  93. 93.

    Furlong E. T. Batt A. L. Glassmeyer S. T. Noriega M. C. Kolpin D. W. Mash H. (2017 ). Nationwide reconnaissance of contaminants of emerging concern in source and treated drinking waters of the United States: pharmaceuticals. Sci. Total Environ. 579 1629–1642.

    Not in our library10.1016/j.scitotenv.2016.03.128

  94. 94.

    Gajski G. Gerić M. Negura B. Novak M. Nunić J. Bajrektarević D. (2016 ). Genotoxic potential of selected cytostatic drugs in human and zebrafish cells. Environ. Sci. Pollut. Res. 23 14739–14750.

    Not in our library10.1007/s11356-015-4592-6

  95. 95.

    Gani K. M. Hlongwa N. Abunama T. Kumari S. Bux F. (2021 ). Emerging contaminants in South African water environment- a critical review of their occurrence, sources and ecotoxicological risks. Chemosphere 269:128737.

    Not in our library10.1016/j.chemosphere.2020.128737

  96. 96.

    García J. García-Galán M. J. Day J. W. Boopathy R. White J. R. Wallace S. (2020 ). A review of emerging organic contaminants (EOCs), antibiotic resistant bacteria (ARB), and antibiotic resistance genes (ARGs) in the environment: increasing removal with wetlands and reducing environmental impacts. Bioresour. Technol. 307:123228.

    Not in our library10.1016/j.biortech.2020.123228

  97. 97.

    Giebułtowicz J. Tyski S. Wolinowska R. Grzybowska W. Zarȩba T. Drobniewska A. (2018 ). Occurrence of antimicrobial agents, drug-resistant bacteria, and genes in the sewage-impacted Vistula River (Poland). Environ. Sci. Pollut. Res. 25, 5788–5807.

    Not in our library10.1007/s11356-017-0861-x

  98. 98.

    Gil A. García A. M. Fernández M. Vicente M. A. González-Rodríguez B. Rives V. (2017 ). Effect of dopants on the structure of titanium oxide used as a photocatalyst for the removal of emergent contaminants. J. Ind. Eng. Chem. 53 183–191.

    Not in our library10.1016/j.jiec.2017.04.024

  99. 99.

    Gillings M. R. Gaze W. H. Pruden A. Smalla K. Tiedje J. M. Zhu Y.-G. (2015 ). Using the class 1 integron-integrase gene as a proxy for anthropogenic pollution. ISME J. 9 1269–1279.

    Not in our library10.1038/ismej.2014.226

  100. 100.

    Godlewska K. Jakubus A. Stepnowski P. Paszkiewicz M. (2021 ). Impact of environmental factors on the sampling rate of β-blockers and sulfonamides from water by a carbon nanotube-passive sampler. J. Environ. Sci. 101 413–427.

    Not in our library10.1016/j.jes.2020.08.034

  101. 101.

    Godoy A. A. Oliveira ÁC. Silva J. G. M. Azevedo C. C. J. Domingues I. Nogueira A. J. A. (2019 ). Single and mixture toxicity of four pharmaceuticals of environmental concern to aquatic organisms, including a behavioral assessment. Chemosphere 235 373–382.

    Not in our library10.1016/j.chemosphere.2019.06.200

  102. 102.

    Golveia J. C. S. Santiago M. F. Sales P. T. F. Sartoratto A. Ponezi A. N. Thomaz D. V. (2018 ). Cupuaçu (Theobroma grandiflorum) residue and its potential application in the bioremediation of 17-A -ethinylestradiol as a Pycnoporus sanguineus laccase inducer. Prep. Biochem. Biotechnol. 48 541–548.

    Not in our library10.1080/10826068.2018.1466161

  103. 103.

    González-Alonso S. Merino L. M. Esteban S. López de Alda M. Barceló D. Durán J. J. (2017 ). Occurrence of pharmaceutical, recreational and psychotropic drug residues in surface water on the northern Antarctic Peninsula region. Environ. Pollut. 229 241–254.

    Not in our library10.1016/j.envpol.2017.05.060

  104. 104.

    González-Pleiter M. Gonzalo S. Rodea-Palomares I. Leganés F. Rosal R. Boltes K. (2013 ). Toxicity of five antibiotics and their mixtures towards photosynthetic aquatic organisms: implications for environmental risk assessment. Water Res. 47 2050–2064.

    Not in our library10.1016/j.watres.2013.01.020

  105. 105.

    Gonzalez-Rey M. Bebianno M. J. (2014 ). Effects of non-steroidal anti-inflammatory drug (NSAID) diclofenac exposure in mussel Mytilus galloprovincialis. Aquat. Toxicol. 148 221–230.

    Not in our library10.1016/j.aquatox.2014.01.011

  106. 106.

    Gore A. C. Crews D. Doan L. L. La Merrill M. Patisaul H. Zota A. (2014 ). Introduction to Endocrine Disrupting Chemicals (EDCs). A Guide for Public Interest Organizations and Policy-Makers. Washington, DC: Endocrine Society, 21–22.

    Not in our library

  107. 107.

    Gothwal R. Shashidhar T. (2015 ). Antibiotic pollution in the environment: a review. CLEAN – Soil Air Water 43 479–489.

    Not in our library10.1002/clen.201300989

  108. 108.

    Grassi M. Kaykioglu G. Belgiorno V. Lofrano G. (2012 ). “Removal of emerging contaminants from water and wastewater by adsorption process,” in Emerging Compounds Removal From Wastewater: Natural and Solar Based Treatments, ed. Lofrano G. (Dordrecht: Springer Netherlands), 15–37.

    Not in our library10.1007/978-94-007-3916-1_2

  109. 109.

    Gravel A. Wilson J. M. Pedro D. F. N. Vijayan M. M. (2009 ). Non-steroidal anti-inflammatory drugs disturb the osmoregulatory, metabolic and cortisol responses associated with seawater exposure in rainbow trout. Comp. Biochem. Physiol. Part C Toxicol. Pharmacol. 149 481–490.

    Not in our library10.1016/j.cbpc.2008.11.002

  110. 110.

    Grenni P. Ancona V. Barra Caracciolo A. (2018 ). Ecological effects of antibiotics on natural ecosystems: a review. Microchem. J. 136 25–39.

    Not in our library10.1016/j.microc.2017.02.006

  111. 111.

    Gröger T. M. Käfer U. Zimmermann R. (2020 ). Gas chromatography in combination with fast high-resolution time-of-flight mass spectrometry: technical overview and perspectives for data visualization. TrAC Trends Anal. Chem. 122:115677.

    Not in our library10.1016/j.trac.2019.115677

  112. 112.

    Gros M. Cruz-Morato C. Marco-Urrea E. Longrée P. Singer H. Sarrà M. (2014 ). Biodegradation of the X-ray contrast agent iopromide and the fluoroquinolone antibiotic ofloxacin by the white rot fungus Trametes versicolor in hospital wastewaters and identification of degradation products. Water Res. 60 228–241.

    Not in our library10.1016/j.watres.2014.04.042

  113. 113.

    Gros M. Marti E. Balcázar J. L. Boy-Roura M. Busquets A. Colón J. (2019 ). Fate of pharmaceuticals and antibiotic resistance genes in a full-scale on-farm livestock waste treatment plant. J. Hazard. Mater. 378:120716.

    Not in our library10.1016/j.jhazmat.2019.05.109

  114. 114.

    Gros M. Petrović M. Ginebreda A. Barceló D. (2010 ). Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ. Int. 36 15–26.

    Not in our library10.1016/j.envint.2009.09.002

  115. 115.

    Hachi M. Chergui A. Yeddou A. R. Selatnia A. Cabana H. (2017 ). Removal of acetaminophen and carbamazepine in single and binary systems with immobilized laccase from Trametes hirsuta. Biocatal. Biotransform. 35 51–62.

    Not in our library10.1080/10242422.2017.1280032

  116. 116.

    Hamid H. Eskicioglu C. (2012 ). Fate of estrogenic hormones in wastewater and sludge treatment: a review of properties and analytical detection techniques in sludge matrix. Water Res. 46 5813–5833.

    Not in our library10.1016/j.watres.2012.08.002

  117. 117.

    Hanna N. Sun P. Sun Q. Li X. Yang X. Ji X. (2018 ). Presence of antibiotic residues in various environmental compartments of Shandong province in eastern China: its potential for resistance development and ecological and human risk. Environ. Int. 114 131–142.

    Not in our library10.1016/j.envint.2018.02.003

  118. 118.

    Harrabi M. Varela Della Giustina S. Aloulou F. Rodriguez-Mozaz S. Barceló D. Elleuch B. (2018 ). Analysis of multiclass antibiotic residues in urban wastewater in Tunisia. Environ. Nanotechnol. Monit. Manage. 10, 163–170.

    Not in our library10.1016/j.enmm.2018.05.006

  119. 119.

    Hawkins T. (2010 ). Understanding and managing the adverse effects of antiretroviral therapy. Antiviral Res. 85 201–209.

    Not in our library10.1016/j.antiviral.2009.10.016

  120. 120.

    Heath E. Filipiè M. Kosjek T. Isidori M. (2016 ). Fate and effects of the residues of anticancer drugs in the environment. Environ. Sci. Pollut. Res. 23 14687–14691.

    Not in our library10.1007/s11356-016-7069-3

  121. 121.

    Heindel J. J. Newbold R. Schug T. T. (2015 ). Endocrine disruptors and obesity. Nat. Rev. Endocrinol. 11 653–661.

    Not in our library10.1038/nrendo.2015.163

  122. 122.

    Hendricks R. Pool E. J. (2012 ). The effectiveness of sewage treatment processes to remove faecal pathogens and antibiotic residues. J. Environ. Sci. Health A 47, 289–297.

    Not in our library10.1080/10934529.2012.637432

  123. 123.

    Hoeger B. Köllner B. Dietrich D. R. Hitzfeld B. (2005 ). Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario). Aquat. Toxicol. 75 53–64.

    Not in our library10.1016/j.aquatox.2005.07.006

  124. 124.

    Hu Y. Jiang L. Sun X. Wu J. Ma L. Zhou Y. (2021 ). Risk assessment of antibiotic resistance genes in the drinking water system. Sci. Total Environ. 800:149650.

    Not in our library10.1016/j.scitotenv.2021.149650

  125. 125.

    Huggett D. B. Brooks B. W. Peterson B. Foran C. M. Schlenk D. (2002 ). Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (b-blockers) on aquatic organisms. Arch. Environ. Contam. Toxicol. 43 229–235.

    Not in our library10.1007/s00244-002-1182-7

  126. 126.

    Hurtado-Gonzalez P. Anderson R. A. Macdonald J. van den Driesche S. Kilcoyne K. Jørgensen A. (2021 ). Effects of exposure to acetaminophen and ibuprofen on fetal germ cell development in both sexes in rodent and human using multiple experimental systems. Environ. Health Perspect. 126:47006.

    Not in our library10.1289/ehp2307

  127. 127.
    Reduction of Antibiotic Resistant Bacteria During Conventional and Advanced Wastewater Treatment, and the Disseminated Loads Released to the Environment · 2018
    Not checked
  128. 128.

    Jebapriya G. R. Gnanadoss J. J. (2013 ). Bioremediation of textile dye using white rot fungi: a review. Int. J. Curr. Res. Rev. 5:1.

    Not in our library

  129. 129.

    Jelic A. Cruz-Morató C. Marco-Urrea E. Sarrà M. Perez S. Vicent T. (2012 ). Degradation of carbamazepine by Trametes versicolor in an air pulsed fluidized bed bioreactor and identification of intermediates. Water Res. 46 955–964.

    Not in our library10.1016/j.watres.2011.11.063

  130. 130.

    Jiao S. Lu Y. (2020 ). Abundant fungi adapt to broader environmental gradients than rare fungi in agricultural fields. Glob. Chang. Biol. 26 4506–4520.

    Not in our library10.1111/gcb.15130

  131. 131.
    Environmental occurrence and ecological risks of psychoactive substances · 2022
    Not checked
  132. 132.

    Johnson A. C. Jürgens M. D. Williams R. J. Kümmerer K. Kortenkamp A. Sumpter J. P. (2008 ). Do cytotoxic chemotherapy drugs discharged into rivers pose a risk to the environment and human health? An overview and UK case study. J. Hydrol. 348 167–175.

    Not in our library10.1016/j.jhydrol.2007.09.054

  133. 133.

    Kairigo P. Ngumba E. Sundberg L.-R. Gachanja A. Tuhkanen T. (2020 ). Occurrence of antibiotics and risk of antibiotic resistance evolution in selected Kenyan wastewaters, surface waters and sediments. Sci. Total Environ. 720:137580.

    Not in our library10.1016/j.scitotenv.2020.137580

  134. 134.

    Kaloudas D. Pavlova N. Penchovsky R. (2021 ). Phycoremediation of wastewater by microalgae: a review. Environ. Chem. Lett. 19 2905–2920.

    Not in our library10.1007/s10311-021-01203-0

  135. 135.

    Kang A. J. Brown A. K. Wong C. S. Yuan Q. (2018 ). Removal of antibiotic sulfamethoxazole by anoxic/anaerobic/oxic granular and suspended activated sludge processes. Bioresour. Technol. 251 151–157.

    Not in our library10.1016/j.biortech.2017.12.021

  136. 136.

    Kang B. R. Kim S. Y. Kang M. Lee T. K. (2021 ). Removal of pharmaceuticals and personal care products using native fungal enzymes extracted during the ligninolytic process. Environ. Res. 195:110878.

    Not in our library10.1016/j.envres.2021.110878

  137. 137.

    Karkman A. Do T. T. Walsh F. Virta M. P. J. (2018 ). Antibiotic-resistance genes in waste water. Trends Microbiol. 26 220–228.

    Not in our library10.1016/j.tim.2017.09.005

  138. 138.

    Kebede T. G. Dube S. Nindi M. M. (2018 ). Removal of non-steroidal anti-inflammatory drugs (NSAIDs) and carbamazepine from wastewater using water-soluble protein extracted from Moringa stenopetala seeds. J. Environ. Chem. Eng. 6 3095–3103.

    Not in our library10.1016/j.jece.2018.04.066

  139. 139.

    Kim J.-W. Jang H.-S. Kim J.-G. Ishibashi H. Hirano M. Nasu K. (2009 ). Occurrence of pharmaceutical and personal care products (PPCPs) in surface water from Mankyung River, South Korea. J. Health Sci. 55, 249–258.

    Not in our library10.1248/jhs.55.249

  140. 140.

    Kim Y. Jung J. Kim M. Park J. Boxall A. B. A. Choi K. (2008 ). Prioritizing veterinary pharmaceuticals for aquatic environment in Korea. Environ. Toxicol. Pharmacol. 26 167–176.

    Not in our library10.1016/j.etap.2008.03.006

  141. 141.

    Kollef M. H. Bassetti M. Francois B. Burnham J. Dimopoulos G. Garnacho-Montero J. (2017 ). The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship. Intensive Care Med. 43 1187–1197.

    Not in our library10.1007/s00134-017-4682-7

  142. 142.

    Kołodziejska M. Maszkowska J. Białk-Bielińska A. Steudte S. Kumirska J. Stepnowski P. (2013 ). Aquatic toxicity of four veterinary drugs commonly applied in fish farming and animal husbandry. Chemosphere 92 1253–1259.

    Not in our library10.1016/j.chemosphere.2013.04.057

  143. 143.

    K’oreje K. O. Demeestere K. De Wispelaere P. Vergeynst L. Dewulf J. Van Langenhove H. (2012 ). From multi-residue screening to target analysis of pharmaceuticals in water: development of a new approach based on magnetic sector mass spectrometry and application in the Nairobi River basin, Kenya. Sci. Total Environ. 437, 153–164.

    Not in our library10.1016/j.scitotenv.2012.07.052

  144. 144.

    K’oreje K. O. Kandie F. J. Vergeynst L. Abira M. A. Van Langenhove H. Okoth M. (2018 ). Occurrence, fate and removal of pharmaceuticals, personal care products and pesticides in wastewater stabilization ponds and receiving rivers in the Nzoia Basin, Kenya. Sci. Total Environ. 637–638, 336–348.

    Not in our library10.1016/j.scitotenv.2018.04.331

  145. 145.

    Kovács R. Csenki Z. Bakos K. Urbányi B. Horváth Á Garaj-Vrhovac V. (2015 ). Assessment of toxicity and genotoxicity of low doses of 5-fluorouracil in zebrafish (Danio rerio) two-generation study. Water Res. 77 201–212.

    Not in our library10.1016/j.watres.2015.03.025

  146. 146.

    Kovalova L. Siegrist H. Singer H. Wittmer A. McArdell C. S. (2012 ). Hospital wastewater treatment by membrane bioreactor: performance and efficiency for organic micropollutant elimination. Environ. Sci. Technol. 46, 1536–1545.

    Not in our library10.1021/es203495d

  147. 147.

    Křesinová Z. Linhartová L. Filipová A. Ezechiáń M. Mańín P. Cajthaml T. (2018 ). Biodegradation of endocrine disruptors in urban wastewater using Pleurotus ostreatus bioreactor. N. Biotechnol. 43 53–61.

    Not in our library10.1016/j.nbt.2017.05.004

  148. 148.

    Kryczyk-Poprawa A. Żmudzki P. Maślanka A. Piotrowska J. Opoka W. Muszyńska B. (2019 ). Mycoremediation of azole antifungal agents using in vitro cultures of Lentinula edodes. 3 Biotech 9:207.

    Not in our library

  149. 149.

    Kümmerer K. (2009 ). Antibiotics in the aquatic environment – a review – Part I. Chemosphere 75 417–434.

    Not in our library10.1016/j.chemosphere.2008.11.086

  150. 150.

    Kümmerer K. Al-Ahmad A. Bertram B. Wießler M. (2000 ). Biodegradability of antineoplastic compounds in screening tests: influence of glucosidation and of stereochemistry. Chemosphere 40 767–773.

    Not in our library10.1016/s0045-6535(99)00451-8

  151. 151.

    Kurade M. B. Ha Y.-H. Xiong J.-Q. Govindwar S. P. Jang M. Jeon B.-H. (2021 ). Phytoremediation as a green biotechnology tool for emerging environmental pollution: a step forward towards sustainable rehabilitation of the environment. Chem. Eng. J. 415:129040.

    Not in our library10.1016/j.cej.2021.129040

  152. 152.

    Letsinger S. Kay P. Rodríguez-Mozaz S. Villagrassa M. Barceló D. Rotchell J. M. (2019 ). Spatial and temporal occurrence of pharmaceuticals in UK estuaries. Sci. Total Environ. 678 74–84.

    Not in our library10.1016/j.scitotenv.2019.04.182

  153. 153.

    Li C. Wei Y. Zhang S. Tan W. (2020 ). Advanced methods to analyze steroid estrogens in environmental samples. Environ. Chem. Lett. 18 543–559.

    Not in our library10.1007/s10311-019-00961-2

  154. 154.

    Lian L. Yao B. Hou S. Fang J. Yan S. Song W. (2017 ). Kinetic study of hydroxyl and sulfate radical-mediated oxidation of pharmaceuticals in wastewater effluents. Environ. Sci. Technol. 51 2954–2962.

    Not in our library10.1021/acs.est.6b05536

  155. 155.

    Lin A. Y.-C. Tsai Y.-T. (2009 ). Occurrence of pharmaceuticals in Taiwan’s surface waters: impact of waste streams from hospitals and pharmaceutical production facilities. Sci. Total Environ. 407 3793–3802.

    Not in our library10.1016/j.scitotenv.2009.03.009

  156. 156.

    Lin A. Y.-C. Yu T.-H. Lin C.-F. (2008 ). Pharmaceutical contamination in residential, industrial, and agricultural waste streams: risk to aqueous environments in Taiwan. Chemosphere 74 131–141.

    Not in our library10.1016/j.chemosphere.2008.08.027

  157. 157.

    Lindberg R. Jarnheimer P. -Å Olsen B. Johansson M. Tysklind M. (2004 ). Determination of antibiotic substances in hospital sewage water using solid phase extraction and liquid chromatography/mass spectrometry and group analogue internal standards. Chemosphere 57 1479–1488.

    Not in our library10.1016/j.chemosphere.2004.09.015

  158. 158.

    Lishman L. Smyth S. A. Sarafin K. Kleywegt S. Toito J. Peart T. (2006 ). Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. Sci. Total Environ. 367, 544–558.

    Not in our library10.1016/j.scitotenv.2006.03.021

  159. 159.

    Lister A. L. Van Der Kraak G. J. (2009 ). Regulation of prostaglandin synthesis in ovaries of sexually-mature zebrafish (Danio rerio). Mol. Reprod. Dev. 76 1064–1075.

    Not in our library10.1002/mrd.21072

  160. 160.

    Liu J. Luo Q. Huang Q. (2016 ). Removal of 17 β-estradiol from poultry litter via solid state cultivation of lignolytic fungi. J. Clean. Prod. 139 1400–1407.

    Not in our library10.1016/j.jclepro.2016.09.020

  161. 161.
    Large-scale biogeographical patterns of bacterial antibiotic resistome in the waterbodies of China · 2018
    Not checked
  162. 162.

    Lloret L. Eibes G. Lú-Chau T. A. Moreira M. T. Feijoo G. Lema J. M. (2010 ). Laccase-catalyzed degradation of anti-inflammatories and estrogens. Biochem. Eng. J. 51 124–131.

    Not in our library10.1016/j.bej.2010.06.005

  163. 163.

    López-Serna R. Jurado A. Vázquez-Suñé E. Carrera J. Petrović M. Barceló D. (2013 ). Occurrence of 95 pharmaceuticals and transformation products in urban groundwaters underlying the metropolis of Barcelona, Spain. Environ. Pollut. 174 305–315.

    Not in our library10.1016/j.envpol.2012.11.022

  164. 164.

    Madikizela L. M. Ncube S. Chimuka L. (2020 ). Analysis, occurrence and removal of pharmaceuticals in African water resources: a current status. J. Environ. Manage. 253:109741.

    Not in our library10.1016/j.jenvman.2019.109741

  165. 165.

    Mamta S. Bhushan S. Rana M. S. Raychaudhuri S. Simsek H. Prajapati S. K. (2020 ). “15 - Algae- and bacteria-driven technologies for pharmaceutical remediation in wastewater,” in Removal of Toxic Pollutants Through Microbiological and Tertiary Treatment, ed. Shah T. T. (Amsterdam: Elsevier), 373–408.

    Not in our library10.1016/b978-0-12-821014-7.00015-0

  166. 166.

    Marcoux M.-A. Matias M. Olivier F. Keck G. (2013 ). Review and prospect of emerging contaminants in waste – Key issues and challenges linked to their presence in waste treatment schemes: general aspects and focus on nanoparticles. Waste Manag. 33 2147–2156.

    Not in our library10.1016/j.wasman.2013.06.022

  167. 167.

    Masoner J. R. Kolpin D. W. Furlong E. T. Cozzarelli I. M. Gray J. L. Schwab E. A. (2014 ). Contaminants of emerging concern in fresh leachate from landfills in the conterminous United States. Environ. Sci. Process. Impacts 16, 2335–2354.

    Not in our library10.1039/c4em00124a

  168. 168.

    Marotta V. Russo G. Gambardella C. Grasso M. La Sala D. Chiofalo M. G. (2019 ). Human exposure to bisphenol AF and diethylhexylphthalate increases susceptibility to develop differentiated thyroid cancer in patients with thyroid nodules. Chemosphere 218 885–894.

    Not in our library10.1016/j.chemosphere.2018.11.084

  169. 169.

    Mashi B. H. (2013 ). Biorremediation: issues and challenges. JORIND 11 1596–1603.

    Not in our library

  170. 170.

    Matongo S. Birungi G. Moodley B. Ndungu P. (2015 ). Occurrence of selected pharmaceuticals in water and sediment of Umgeni River, KwaZulu-Natal, South Africa. Environ. Sci. Pollut. Res. 22, 10298–10308.

    Not in our library10.1007/s11356-015-4217-0

  171. 171.

    de Jesus Menk J. do Nascimento A. I. S. Leite F. G. de Oliveira R. A. Jozala A. F. (2019 ). Biosorption of pharmaceutical products by mushroom stem waste. Chemosphere 237:124515.

    Not in our library10.1016/j.chemosphere.2019.124515

  172. 172.

    Migliore L. Fiori M. Spadoni A. Galli E. (2012 ). Biodegradation of oxytetracycline by Pleurotus ostreatus mycelium: a mycoremediation technique. J. Hazard. Mater. 21 227–232.

    Not in our library10.1016/j.jhazmat.2012.02.056

  173. 173.

    Minguez L. Pedelucq J. Farcy E. Ballandonne C. Budzinski H. Halm-Lemeille M.-P. (2016 ). Toxicities of 48 pharmaceuticals and their freshwater and marine environmental assessment in northwestern France. Environ. Sci. Pollut. Res. 23 4992–5001.

    Not in our library10.1007/s11356-014-3662-5

  174. 174.

    Mlunguza N. Y. Ncube S. Mahlambi P. N. Chimuka L. Madikizela L. M. (2020 ). Determination of selected antiretroviral drugs in wastewater, surface water and aquatic plants using hollow fibre liquid phase microextraction and liquid chromatography - tandem mass spectrometry. J. Hazard. Mater. 382:121067.

    Not in our library10.1016/j.jhazmat.2019.121067

  175. 175.

    Morelli K. M. Brown L. B. Warren G. L. (2017 ). Effect of NSAIDs on recovery from acute skeletal muscle injury: a systematic review and meta-analysis. Am. J. Sports Med. 46 224–233.

    Not in our library10.1177/0363546517697957

  176. 176.

    Mosekiemang T. T. Stander M. A. de Villiers A. (2019 ). Simultaneous quantification of commonly prescribed antiretroviral drugs and their selected metabolites in aqueous environmental samples by direct injection and solid phase extraction liquid chromatography - tandem mass spectrometry. Chemosphere 220 983–992.

    Not in our library10.1016/j.chemosphere.2018.12.205

  177. 177.

    Mtolo S. P. Mahlambi P. N. Madikizela L. M. (2019 ). Synthesis and application of a molecularly imprinted polymer in selective solid-phase extraction of efavirenz from water. Water Sci. Technol. 79 356–365.

    Not in our library10.2166/wst.2019.054

  178. 178.

    Mukhtar A. Manzoor M. Gul I. Zafar R. Jamil H. I. Niazi A. K. (2020 ). Phytotoxicity of different antibiotics to rice and stress alleviation upon application of organic amendments. Chemosphere 258:127353.

    Not in our library10.1016/j.chemosphere.2020.127353

  179. 179.

    Mupatsi N. (2020 ). Observed and potential environmental impacts of COVID-19 in Africa. Preprints 2020080442.

    Not in our library10.20944/preprints202008.0442.v1

  180. 180.

    Muszyńska B. Dąbrowska M. Starek M. Żmudzki P. Lazur J. Pytko-Polończyk J. (2019 ). Lentinula edodes Mycelium as effective agent for piroxicam mycoremediation. Front. Microbiol. 10:313.

    Not in our library10.3389/fmicb.2019.00313

  181. 181.

    Muszyńska B. Żmudzki P. Lazur J. Kała K. Sułkowska-Ziaja K. Opoka W. (2018 ). Analysis of the biodegradation of synthetic testosterone and 17α-ethynylestradiol using the edible mushroom Lentinula edodes. 3 Biotech 8:424.

    Not in our library10.1007/s13205-018-1458-x

  182. 182.

    Nadal A. Quesada I. Tudurí E. Nogueiras R. Alonso-Magdalena P. (2017 ). Endocrine-disrupting chemicals and the regulation of energy balance. Nat. Rev. Endocrinol. 13 536–546.

    Not in our library10.1038/nrendo.2017.51

  183. 183.

    Nadimpalli M. L. Marks S. J. Montealegre M. C. Gilman R. H. Pajuelo M. J. Saito M. (2020 ). Urban informal settlements as hotspots of antimicrobial resistance and the need to curb environmental transmission. Nat. Microbiol. 5 787–795.

    Not in our library10.1038/s41564-020-0722-0

  184. 184.

    Nakada N. Tanishima T. Shinohara H. Kiri K. Takada H. (2006 ). Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Res. 40, 3297–3303.

    Not in our library10.1016/j.watres.2006.06.039

  185. 185.

    Nannou C. Ofrydopoulou A. Evgenidou E. Heath D. Heath E. Lambropoulou D. (2020 ). Antiviral drugs in aquatic environment and wastewater treatment plants: a review on occurrence, fate, removal and ecotoxicity. Sci. Total Environ. 699:134322.

    Not in our library10.1016/j.scitotenv.2019.134322

  186. 186.

    Nantaba F. Wasswa J. Kylin H. Palm W.-U. Bouwman H. Kümmerer K. (2020 ). Occurrence, distribution, and ecotoxicological risk assessment of selected pharmaceutical compounds in water from Lake Victoria, Uganda. Chemosphere 239:124642.

    Not in our library10.1016/j.chemosphere.2019.124642

  187. 187.

    Nassour C. Barton S. J. Nabhani-Gebara S. Saab Y. Barker J. (2020 ). Occurrence of anticancer drugs in the aquatic environment: a systematic review. Environ. Sci. Pollut. Res. 27 1339–1347.

    Not in our library10.1007/s11356-019-07045-2

  188. 188.

    Ncube S. Madikizela L. M. Chimuka L. Nindi M. M. (2018 ). Environmental fate and ecotoxicological effects of antiretrovirals: a current global status and future perspectives. Water Res. 145 231–247.

    Not in our library10.1016/j.watres.2018.08.017

  189. 189.

    Negreira N. de Alda M. L. Barceló D. (2014 ). Cytostatic drugs and metabolites in municipal and hospital wastewaters in Spain: filtration, occurrence, and environmental risk. Sci. Total Environ. 497–498, 68–77.

    Not in our library10.1016/j.scitotenv.2014.07.101

  190. 190.

    Ngumba E. Gachanja A. Nyirenda J. Maldonado J. Tuhkanen T. (2020 ). Occurrence of antibiotics and antiretroviral drugs in source-separated urine, groundwater, surface water and wastewater in the peri-urban area of Chunga in Lusaka, Zambia. Water SA 46, 278–284.

    Not in our library10.17159/wsa/2020.v46.i2.8243

  191. 191.

    Ngumba E. Gachanja A. Tuhkanen T. (2016 ). Occurrence of selected antibiotics and antiretroviral drugs in Nairobi River Basin, Kenya. Sci. Total Environ. 539 206–213.

    Not in our library10.1016/j.scitotenv.2015.08.139

  192. 192.

    Nguyen L. N. Hai F. I. Yang S. Kang J. Leusch F. D. L. Roddick F. (2013 ). Removal of trace organic contaminants by an MBR comprising a mixed culture of bacteria and white-rot fungi. Bioresour. Technol. 148 234–241.

    Not in our library10.1016/j.biortech.2013.08.142

  193. 193.

    Nguyen L. N. Hai F. I. Yang S. Kang J. Leusch F. D. L. Roddick F. (2014 ). Removal of pharmaceuticals, steroid hormones, phytoestrogens, UV-filters, industrial chemicals and pesticides by Trametes versicolor: role of biosorption and biodegradation. Int. Biodeterior. Biodegrad. 88 169–175.

    Not in our library10.1016/j.ibiod.2013.12.017

  194. 194.

    Nie X.-P. Liu B.-Y. Yu H.-J. Liu W.-Q. Yang Y.-F. (2013 ). Toxic effects of erythromycin, ciprofloxacin and sulfamethoxazole exposure to the antioxidant system in Pseudokirchneriella subcapitata. Environ. Pollut. 172 23–32.

    Not in our library10.1016/j.envpol.2012.08.013

  195. 195.

    Ogwugwa V. H. Oyetibo G. O. Amund O. O. (2021 ). Taxonomic profiling of bacteria and fungi in freshwater sewer receiving hospital wastewater. Environ. Res. 192:110319.

    Not in our library10.1016/j.envres.2020.110319

  196. 196.

    Ojemaye C. Y. Petrik L. (2018 ). Pharmaceuticals in the marine environment: a review. Environ. Rev. 27 151–165.

    Not in our library10.1139/er-2018-0054

  197. 197.

    Olaitan O. J. Okunuga Y. O. Kasim L. S. Chimezie A. Oderinde O. (2017 ). Determination of selected antimalarial pharmaceuticals in water from two hospital environments in Abeokuta Ogun state-Nigeria using SPE-LC. Afr. J. Sci. Nat. 3, 50–56.

    Not in our library

  198. 198.

    Olicón-Hernández D. R. Camacho-Morales R. L. Pozo C. González-López J. Aranda E. (2019 ). Evaluation of diclofenac biodegradation by the ascomycete fungus Penicillium oxalicum at flask and bench bioreactor scales. Sci. Total Environ. 662 607–614.

    Not in our library10.1016/j.scitotenv.2019.01.248

  199. 199.

    Olicón-Hernández D. R. Gómez-Silván C. Pozo C. Andersen G. L. González-Lopez J. Aranda E. (2021 ). Penicillium oxalicum XD-3.1 removes pharmaceutical compounds from hospital wastewater and outcompetes native bacterial and fungal communities in fluidised batch bioreactors. Int. Biodeterior. Biodegrad. 158:105179.

    Not in our library10.1016/j.ibiod.2021.105179

  200. 200.
    Overview on the Biochemical Potential of Filamentous Fungi to Degrade Pharmaceutical Compounds · 2017
    Not checked
  201. 201.

    Olicón-Hernández D. R. Ortúzar M. Pozo C. González-López J. Aranda E. (2020 ). Metabolic capability of penicillium oxalicum to transform high concentrations of anti-inflammatory and analgesic drugs. Appl. Sci. 10:2479.

    Not in our library10.3390/app10072479

  202. 202.

    Palanisamy V. Gajendiran V. Mani K. (2021 ). Meta-analysis to identify the core microbiome in diverse wastewater. Int. J. Environ. Sci. Technol. 1–18.

    Not in our library10.1007/s13762-021-03349-4

  203. 203.

    Palli L. Castellet-Rovira F. Pérez-Trujillo M. Caniani D. Sarrà-Adroguer M. Gori R. (2017 ). Preliminary evaluation of Pleurotus ostreatus for the removal of selected pharmaceuticals from hospital wastewater. Biotechnol. Prog. 33 1529–1537.

    Not in our library10.1002/btpr.2520

  204. 204.

    Pan M. Chu L. M. (2017 ). Fate of antibiotics in soil and their uptake by edible crops. Sci. Total Environ. 599–600 500–512.

    Not in our library10.1016/j.scitotenv.2017.04.214

  205. 205.

    Park H. Choi I.-G. (2020 ). Genomic and transcriptomic perspectives on mycoremediation of polycyclic aromatic hydrocarbons. Appl. Microbiol. Biotechnol. 104 6919–6928.

    Not in our library10.1007/s00253-020-10746-1

  206. 206.

    Parolini M. (2020 ). Toxicity of the non-steroidal anti-inflammatory drugs (NSAIDs) acetylsalicylic acid, paracetamol, diclofenac, ibuprofen and naproxen towards freshwater invertebrates: a review. Sci. Total Environ. 740:140043.

    Not in our library10.1016/j.scitotenv.2020.140043

  207. 207.

    Peng X. Yu Y. Tang C. Tan J. Huang Q. Wang Z. (2008 ). Occurrence of steroid estrogens, endocrine-disrupting phenols, and acid pharmaceutical residues in urban riverine water of the Pearl River Delta, South China. Sci. Total Environ. 397 158–166.

    Not in our library10.1016/j.scitotenv.2008.02.059

  208. 208.

    Peng X. Zhang K. Tang C. Huang Q. Yu Y. Cui J. (2011 ). Distribution pattern, behavior, and fate of antibacterials in urban aquatic environments in South China. J. Environ. Monit. 13 446–454.

    Not in our library10.1039/c0em00394h

  209. 209.

    Pereira C. D. S. Maranho L. A. Cortez F. S. Pusceddu F. H. Santos A. R. Ribeiro D. A. (2016 ). Occurrence of pharmaceuticals and cocaine in a Brazilian coastal zone. Sci. Total Environ. 548–549 148–154.

    Not in our library10.1016/j.scitotenv.2016.01.051

  210. 210.

    Phillips P. J. Smith S. G. Kolpin D. W. Zaugg S. D. Buxton H. T. Furlong E. T. (2010 ). Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents. Environ. Sci. Technol. 44 4910–4916.

    Not in our library10.1021/es100356f

  211. 211.

    Pivetta R. C. Rodrigues-Silva C. Ribeiro A. R. Rath S. (2020 ). Tracking the occurrence of psychotropic pharmaceuticals in Brazilian wastewater treatment plants and surface water, with assessment of environmental risks. Sci. Total Environ. 727:138661.

    Not in our library10.1016/j.scitotenv.2020.138661

  212. 212.

    Prasse C. Schlüsener M. P. Schulz R. Ternes T. A. (2010 ). Antiviral drugs in wastewater and surface waters: a new pharmaceutical class of environmental relevance? Environ. Sci. Technol. 44 1728–1735.

    Not in our library10.1021/es903216p

  213. 213.

    Ramírez-Morales D. Masís-Mora M. Beita-Sandí W. Montiel-Mora J. R. Fernández-Fernández E. Méndez-Rivera M. (2021 ). Pharmaceuticals in farms and surrounding surface water bodies: hazard and ecotoxicity in a swine production area in Costa Rica. Chemosphere 272:129574.

    Not in our library10.1016/j.chemosphere.2021.129574

  214. 214.

    Ramírez-Morales D. Masís-Mora M. Montiel-Mora J. R. Cambronero-Heinrichs J. C. Briceño-Guevara S. Rojas-Sánchez C. E. (2020 ). Occurrence of pharmaceuticals, hazard assessment and ecotoxicological evaluation of wastewater treatment plants in Costa Rica. Sci. Total Environ. 746:141200.

    Not in our library10.1016/j.scitotenv.2020.141200

  215. 215.

    Rao P. H. Kumar R. R. Mohan N. (2019 ). “Phycoremediation: role of algae in waste management,” in Environmental Contaminants: Ecological Implications and Management, ed. Bharagava R. N. (Berlin: Springer), 49–82.

    Not in our library10.1007/978-981-13-7904-8_3

  216. 216.

    Rathi B. S. Kumar P. S. Show P.-L. (2021 ). A review on effective removal of emerging contaminants from aquatic systems: current trends and scope for further research. J. Hazard. Mater. 409:124413.

    Not in our library10.1016/j.jhazmat.2020.124413

  217. 217.

    Reddy K. Renuka N. Kumari S. Bux F. (2021 ). Algae-mediated processes for the treatment of antiretroviral drugs in wastewater: prospects and challenges. Chemosphere 280:130674.

    Not in our library10.1016/j.chemosphere.2021.130674

  218. 218.

    Reis-Santos P. Pais M. Duarte B. Caçador I. Freitas A. Vila Pouca A. S. (2018 ). Screening of human and veterinary pharmaceuticals in estuarine waters: a baseline assessment for the Tejo estuary. Mar. Pollut. Bull. 135 1079–1084.

    Not in our library10.1016/j.marpolbul.2018.08.036

  219. 219.

    Ren J. Wang Z. Deng L. Niu D. Huhetaoli, Li Z. (2021 ). Degradation of erythromycin by a novel fungus, Penicillium oxalicum RJJ-2, and the degradation pathway. Waste Biomass Valorization 12 4513–4523.

    Not in our library10.1007/s12649-021-01343-y

  220. 220.

    Reyes N. J. D. G. Geronimo F. K. F. Yano K. A. V. Guerra H. B. Kim L.-H. (2021 ). Pharmaceutical and personal care products in different matrices: occurrence, pathways, and treatment processes. Water 13:1159.

    Not in our library10.3390/w13091159

  221. 221.

    Rimayi C. Odusanya D. Weiss J. M. de Boer J. Chimuka L. (2018 ). Contaminants of emerging concern in the Hartbeespoort Dam catchment and the uMngeni River estuary 2016 pollution incident, South Africa. Sci. Total Environ. 627 1008–1017.

    Not in our library10.1016/j.scitotenv.2018.01.263

  222. 222.

    Rivera-Jaimes J. A. Postigo C. Melgoza-Alemán R. M. Aceña J. Barceló D. López de Alda M. (2018 ). Study of pharmaceuticals in surface and wastewater from Cuernavaca, Morelos, Mexico: occurrence and environmental risk assessment. Sci. Total Environ. 613–614 1263–1274.

    Not in our library10.1016/j.scitotenv.2017.09.134

  223. 223.

    Roberts P. H. Thomas K. V. (2006 ). The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci. Total Environ. 356 143–153.

    Not in our library10.1016/j.scitotenv.2005.04.031

  224. 224.

    Rodarte-Morales A. I. Feijoo G. Moreira M. T. Lema J. M. (2012a ). Biotransformation of three pharmaceutical active compounds by the fungus Phanerochaete chrysosporium in a fed batch stirred reactor under air and oxygen supply. Biodegradation 23 145–156.

    Not in our library10.1007/s10532-011-9494-9

  225. 225.

    Rodarte-Morales A. I. Feijoo G. Moreira M. T. Lema J. M. (2012b ). Operation of stirred tank reactors (STRs) and fixed-bed reactors (FBRs) with free and immobilized Phanerochaete chrysosporium for the continuous removal of pharmaceutical compounds. Biochem. Eng. J. 66 38–45.

    Not in our library10.1016/j.bej.2012.04.011

  226. 226.

    Rodriguez-Mozaz S. Vaz-Moreira I. Varela Della Giustina S. Llorca M. Barceló D. Schubert S. (2020 ). Antibiotic residues in final effluents of European wastewater treatment plants and their impact on the aquatic environment. Environ. Int. 140:105733.

    Not in our library10.1016/j.envint.2020.105733

  227. 227.

    Rouches E. Herpoël-Gimbert I. Steyer J. P. Carrere H. (2016 ). Improvement of anaerobic degradation by white-rot fungi pretreatment of lignocellulosic biomass: a review. Renew. Sustain. Energy Rev. 59 179–198.

    Not in our library10.1016/j.rser.2015.12.317

  228. 228.

    Rowney N. C. Johnson A. C. Williams R. J. (2009 ). Cytotoxic drugs in drinking water: a prediction and risk assessment exercise for the thames catchment in the United Kingdom. Environ. Toxicol. Chem. 28 2733–2743.

    Not in our library10.1897/09-067.1

  229. 229.

    Ruan Y. Lin H. Zhang X. Wu R. Zhang K. Leung K. M. Y. (2020 ). Enantiomer-specific bioaccumulation and distribution of chiral pharmaceuticals in a subtropical marine food web. J. Hazard. Mater. 394:122589.

    Not in our library10.1016/j.jhazmat.2020.122589

  230. 230.

    Russo D. Siciliano A. Guida M. Andreozzi R. Reis N. M. Li Puma G. (2018 ). Removal of antiretroviral drugs stavudine and zidovudine in water under UV254 and UV254/H2O2 processes: quantum yields, kinetics and ecotoxicology assessment. J. Hazard. Mater. 349 195–204.

    Not in our library10.1016/j.jhazmat.2018.01.052

  231. 231.

    Santos J. L. Aparicio I. Alonso E. (2007 ). Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. a case study: Seville city (Spain). Environ. Int. 33, 596–601.

    Not in our library10.1016/j.envint.2006.09.014

  232. 232.

    Santos L. H. M. L. Araújo A. N. Fachini A. Pena A. Delerue-Matos C. Montenegro M. C. B. S. M. (2010 ). Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J. Hazard. Mater. 175 45–95.

    Not in our library10.1016/j.jhazmat.2009.10.100

  233. 233.
    Microplastics as vectors of pharmaceuticals in aquatic organisms – An overview of their environmental implications · 2021
    Not checked
  234. 234.

    Schlüsener M. P. Hardenbicker P. Nilson E. Schulz M. Viergutz C. Ternes T. A. (2015 ). Occurrence of venlafaxine, other antidepressants and selected metabolites in the Rhine catchment in the face of climate change. Environ. Pollut. 196 247–256.

    Not in our library10.1016/j.envpol.2014.09.019

  235. 235.

    Schwaiger J. Ferling H. Mallow U. Wintermayr H. Negele R. D. (2004 ). Toxic effects of the non-steroidal anti-inflammatory drug diclofenac: part I: histopathological alterations and bioaccumulation in rainbow trout. Aquat. Toxicol. 68 141–150.

    Not in our library10.1016/j.aquatox.2004.03.014

  236. 236.

    Segura P. A. Takada H. Correa J. A. El Saadi K. Koike T. Onwona-Agyeman S. (2015 ). Global occurrence of anti-infectives in contaminated surface waters: impact of income inequality between countries. Environ. Int. 80, 89–97.

    Not in our library10.1016/j.envint.2015.04.001

  237. 237.

    Shah A. Shah M. (2020 ). Characterisation and bioremediation of wastewater: a review exploring bioremediation as a sustainable technique for pharmaceutical wastewater. Groundw. Sustain. Dev. 11:100383.

    Not in our library10.1016/j.gsd.2020.100383

  238. 238.

    Shao B. Liu Z. Zeng G. Liu Y. Yang X. Zhou C. (2019 ). Immobilization of laccase on hollow mesoporous carbon nanospheres: noteworthy immobilization, excellent stability and efficacious for antibiotic contaminants removal. J. Hazard. Mater. 362 318–326.

    Not in our library10.1016/j.jhazmat.2018.08.069

  239. 239.

    Sim W.-J. Lee J.-W. Lee E.-S. Shin S.-K. Hwang S.-R. Oh J.-E. (2011 ). Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures. Chemosphere 82 179–186.

    Not in our library10.1016/j.chemosphere.2010.10.026

  240. 240.

    Stadlmair L. F. Letzel T. Drewes J. E. Grassmann J. (2018 ). Enzymes in removal of pharmaceuticals from wastewater: a critical review of challenges, applications and screening methods for their selection. Chemosphere 205 649–661.

    Not in our library10.1016/j.chemosphere.2018.04.142

  241. 241.

    Sui Q. Cao X. Lu S. Zhao W. Qiu Z. Yu G. (2015 ). Occurrence, sources and fate of pharmaceuticals and personal care products in the groundwater: a review. Emerg. Contam. 1 14–24.

    Not in our library10.1016/j.emcon.2015.07.001

  242. 242.

    Svobodníková L. Kummerová M. Zezulka Š Babula P. Sendecká K. (2020 ). Root response in Pisum sativum under naproxen stress: morpho-anatomical, cytological, and biochemical traits. Chemosphere 258:127411.

    Not in our library10.1016/j.chemosphere.2020.127411

  243. 243.

    Świacka K. Michnowska A. Maculewicz J. Caban M. Smolarz K. (2021 ). Toxic effects of NSAIDs in non-target species: a review from the perspective of the aquatic environment. Environ. Pollut. 273:115891.

    Not in our library10.1016/j.envpol.2020.115891

  244. 244.

    Tahrani L. Van Loco J. Anthonissen R. Verschaeve L. Ben Mansour H. Reyns T. (2017 ). Identification and risk assessment of human and veterinary antibiotics in the wastewater treatment plants and the adjacent sea in Tunisia. Water Sci. Technol. 76, 3000–3021.

    Not in our library10.2166/wst.2017.465

  245. 245.

    Tan B. L. L. Hawker D. W. Müller J. F. Leusch F. D. L. Tremblay L. A. Chapman H. F. (2007 ). Modelling of the fate of selected endocrine disruptors in a municipal wastewater treatment plant in South East Queensland, Australia. Chemosphere 69, 644–654.

    Not in our library10.1016/j.chemosphere.2007.02.057

  246. 246.

    Tanoue R. Margiotta-Casaluci L. Huerta B. Runnalls T. J. Eguchi A. Nomiyama K. (2019 ). Protecting the environment from psychoactive drugs: problems for regulators illustrated by the possible effects of tramadol on fish behaviour. Sci. Total Environ. 664 915–926.

    Not in our library10.1016/j.scitotenv.2019.02.090

  247. 247.

    Ternes T. A. (1998 ). Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 32, 3245–3260.

    Not in our library10.1016/s0043-1354(98)00099-2

  248. 248.

    Ternes T. (2001 ). “Pharmaceuticals and metabolites as contaminants of the aquatic environment,” in Pharmaceuticals and Care Products in the Environment ACS Symposium Series, ed. Daughton C. G. (Washington, DC: American Chemical Society), 2–39.

    Not in our library10.1021/bk-2001-0791.ch002

  249. 249.

    Thibaut R. Schnell S. Porte C. (2006 ). The interference of pharmaceuticals with endogenous and xenobiotic metabolizing enzymes in carp liver: an in-vitro study. Environ. Sci. Technol. 40 5154–5160.

    Not in our library10.1021/es0607483

  250. 250.

    Tijani J. O. Fatoba O. O. Babajide O. O. Petrik L. F. (2016 ). Pharmaceuticals, endocrine disruptors, personal care products, nanomaterials and perfluorinated pollutants: a review. Environ. Chem. Lett. 14 27–49.

    Not in our library10.1007/s10311-015-0537-z

  251. 251.

    Tińma M. Nnidarńič-Plazl P. Ńelo G. Tolj I. Ńperanda M. Bucić-Kojić A. (2021 ). Trametes versicolor in lignocellulose-based bioeconomy: state of the art, challenges and opportunities. Bioresour. Technol. 330:124997.

    Not in our library10.1016/j.biortech.2021.124997

  252. 252.

    Tixier C. Singer H. P. Oellers S. Müller S. R. (2003 ). Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ. Sci. Technol. 37, 1061–1068.

    Not in our library10.1021/es025834r

  253. 253.

    Tompsett A. (2020 ). The lazarus drug: the impact of antiretroviral therapy on economic growth. J. Dev. Econ. 143:102409.

    Not in our library10.1016/j.jdeveco.2019.102409

  254. 254.

    Tran N. H. Urase T. Ta T. T. (2014 ). A preliminary study on the occurrence of pharmaceutically active compounds in hospital wastewater and surface water in Hanoi, Vietnam. Clean Soil Air Water 42, 267–275.

    Not in our library10.1002/clen.201300021

  255. 255.

    Triebskorn R. Casper H. Heyd A. Eikemper R. Köhler H.-R. Schwaiger J. (2004 ). Toxic effects of the non-steroidal anti-inflammatory drug diclofenac: Part II. Cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). Aquat. Toxicol. 68 151–166.

    Not in our library10.1016/j.aquatox.2004.03.015

  256. 256.

    Valcárcel Y. González Alonso S. Rodríguez-Gil J. L. Gil A. Catalá M. (2011 ). Detection of pharmaceutically active compounds in the rivers and tap water of the Madrid Region (Spain) and potential ecotoxicological risk. Chemosphere 84 1336–1348.

    Not in our library10.1016/j.chemosphere.2011.05.014

  257. 257.

    Valdez-Carrillo M. Abrell L. Ramírez-Hernández J. Reyes-López J. A. Carreón-Diazconti C. (2020 ). Pharmaceuticals as emerging contaminants in the aquatic environment of Latin America: a review. Environ. Sci. Pollut. Res. 27 44863–44891.

    Not in our library10.1007/s11356-020-10842-9

  258. 258.

    Vasiliadou I. A. Molina R. Pariente M. I. Christoforidis K. C. Martinez F. Melero J. A. (2019 ). Understanding the role of mediators in the efficiency of advanced oxidation processes using white-rot fungi. Chem. Eng. J. 359 1427–1435.

    Not in our library10.1016/j.cej.2018.11.035

  259. 259.

    Vaudreuil M.-A. Vo Duy S. Munoz G. Furtos A. Sauvé S. (2020 ). A framework for the analysis of polar anticancer drugs in wastewater: on-line extraction coupled to HILIC or reverse phase LC-MS/MS. Talanta 220:121407.

    Not in our library10.1016/j.talanta.2020.121407

  260. 260.

    Vergeynst L. Haeck A. De Wispelaere P. Van Langenhove H. Demeestere K. (2015 ). Multi-residue analysis of pharmaceuticals in wastewater by liquid chromatography-magnetic sector mass spectrometry: method quality assessment and application in a Belgian case study. Chemosphere 119, S2–S8.

    Not in our library10.1016/j.chemosphere.2014.03.069

  261. 261.

    Verlicchi P. Galletti A. Petrovic M. Barceló D. (2010 ). Hospital effluents as a source of emerging pollutants: an overview of micropollutants and sustainable treatment options. J. Hydrol. 389 416–428.

    Not in our library10.1016/j.jhydrol.2010.06.005

  262. 262.

    Vidal-Dorsch D. E. Bay S. M. Maruya K. Snyder S. A. Trenholm R. A. Vanderford B. J. (2012 ). Contaminants of emerging concern in municipal wastewater effluents and marine receiving water. Environ. Toxicol. Chem. 31, 2674–2682.

    Not in our library10.1002/etc.2004

  263. 263.

    Vieira W. T. de Farias M. B. Spaolonzi M. P. da Silva M. G. C. Vieira M. G. A. (2020 ). Removal of endocrine disruptors in waters by adsorption, membrane filtration and biodegradation. A review. Environ. Chem. Lett. 18 1113–1143.

    Not in our library10.1007/s10311-020-01000-1

  264. 264.

    Vilvert E. Contardo-Jara V. Esterhuizen-Londt M. Pflugmacher S. (2017 ). The effect of oxytetracycline on physiological and enzymatic defense responses in aquatic plant species Egeria densa, Azolla caroliniana, and Taxiphyllum barbieri. Toxicol. Environ. Chem. 99 104–116.

    Not in our library10.1080/02772248.2016.1165817

  265. 265.

    Wang S. Ma X. Liu Y. Yi X. Du G. Li J. (2020 ). Fate of antibiotics, antibiotic-resistant bacteria, and cell-free antibiotic-resistant genes in full-scale membrane bioreactor wastewater treatment plants. Bioresour. Technol. 302:122825.

    Not in our library10.1016/j.biortech.2020.122825

  266. 266.

    Wang Z. Du Y. Yang C. Liu X. Zhang J. Li E. (2017 ). Occurrence and ecological hazard assessment of selected antibiotics in the surface waters in and around Lake Honghu, China. Sci. Total Environ. 609, 1423–1432.

    Not in our library10.1016/j.scitotenv.2017.08.009

  267. 267.

    Wijaya L. Alyemeni M. Ahmad P. Alfarhan A. Barcelo D. El-Sheikh M. A. (2020 ). Ecotoxicological effects of ibuprofen on plant growth of Vigna unguiculata L. Plants 9:1473.

    Not in our library10.3390/plants9111473

  268. 268.

    Willyard C. (2017 ). The drug-resistant bacteria that pose the greatest health threats. Nature 543:15.

    Not in our library10.1038/nature.2017.21550

  269. 269.

    Wojcieszyńska D. Domaradzka D. Hupert-Kocurek K. Guzik U. (2014 ). Bacterial degradation of naproxen – undisclosed pollutant in the environment. J. Environ. Manage. 145 157–161.

    Not in our library10.1016/j.jenvman.2014.06.023

  270. 270.

    Wollenberger L. Halling-Sørensen B. Kusk K. O. (2000 ). Acute and chronic toxicity of veterinary antibiotics to Daphnia magna. Chemosphere 40 723–730.

    Not in our library10.1016/s0045-6535(99)00443-9

  271. 271.

    Wu J. Qian X. Yang Z. Zhang L. (2010 ). Study on the matrix effect in the determination of selected pharmaceutical residues in seawater by solid-phase extraction and ultra-high-performance liquid chromatography-electrospray ionization low-energy collision-induced dissociation tandem mass spectrometry. J. Chromatogr. A 1217, 1471–1475.

    Not in our library10.1016/j.chroma.2009.12.074

  272. 272.

    Wu S. Zhang L. Chen J. (2012 ). Paracetamol in the environment and its degradation by microorganisms. Appl. Microbiol. Biotechnol. 96 875–884.

    Not in our library10.1007/s00253-012-4414-4

  273. 273.

    Xia L. Zheng L. Zhou J. L. (2017 ). Effects of ibuprofen, diclofenac and paracetamol on hatch and motor behavior in developing zebrafish (Danio rerio). Chemosphere 182 416–425.

    Not in our library10.1016/j.chemosphere.2017.05.054

  274. 274.

    Xu S. Yao J. Ainiwaer M. Hong Y. Zhang Y. (2018 ). Analysis of bacterial community structure of activated sludge from wastewater treatment plants in winter. Biomed Res. Int. 2018:8278970.

    Not in our library10.1155/2018/8278970

  275. 275.

    Yadav A. Rene E. R. Mandal M. K. Dubey K. K. (2021 ). Threat and sustainable technological solution for antineoplastic drugs pollution: review on a persisting global issue. Chemosphere 263:128285.

    Not in our library10.1016/j.chemosphere.2020.128285

  276. 276.

    Yan J. Lin W. Gao Z. Ren Y. (2021 ). Use of selected NSAIDs in Guangzhou and other cities in the world as identified by wastewater analysis. Chemosphere 279:130529.

    Not in our library10.1016/j.chemosphere.2021.130529

  277. 277.

    Yang S. Hai F. I. Nghiem L. D. Nguyen L. N. Roddick F. Price W. E. (2013 ). Removal of bisphenol A and diclofenac by a novel fungal membrane bioreactor operated under non-sterile conditions. Int. Biodeterior. Biodegrad. 85 483–490.

    Not in our library10.1016/j.ibiod.2013.03.012

  278. 278.

    Yang Y. Fu J. Peng H. Hou L. Liu M. Zhou J. L. (2011 ). Occurrence and phase distribution of selected pharmaceuticals in the Yangtze Estuary and its coastal zone. J. Hazard. Mater. 190, 588–596.

    Not in our library10.1016/j.jhazmat.2011.03.092

  279. 279.

    Yu J. T. Bouwer E. J. Coelhan M. (2006 ). Occurrence and biodegradability studies of selected pharmaceuticals and personal care products in sewage effluent. Agric. Water Manage. 86, 72–80.

    Not in our library10.1016/j.agwat.2006.06.015

  280. 280.

    Yu Y. Wu L. Chang A. C. (2013 ). Seasonal variation of endocrine disrupting compounds, pharmaceuticals and personal care products in wastewater treatment plants. Sci. Total Environ. 442 310–316.

    Not in our library10.1016/j.scitotenv.2012.10.001

  281. 281.

    Zafar R. Bashir S. Nabi D. Arshad M. (2021 ). Occurrence and quantification of prevalent antibiotics in wastewater samples from Rawalpindi and Islamabad, Pakistan. Sci. Total Environ. 764:142596.

    Not in our library10.1016/j.scitotenv.2020.142596

  282. 282.

    Zainab S. M. Junaid M. Xu N. Malik R. N. (2020 ). Antibiotics and antibiotic resistant genes (ARGs) in groundwater: a global review on dissemination, sources, interactions, environmental and human health risks. Water Res. 187:116455.

    Not in our library10.1016/j.watres.2020.116455

  283. 283.

    Zhang Q.-Q. Ying G.-G. Pan C.-G. Liu Y.-S. Zhao J.-L. (2015 ). Comprehensive evaluation of antibiotics emission and fate in the river basins of china: source analysis, multimedia modeling, and linkage to bacterial resistance. Environ. Sci. Technol. 49 6772–6782.

    Not in our library10.1021/acs.est.5b00729

  284. 284.

    Zhang Y. Duan L. Wang B. Liu C. S. Jia Y. Zhai N. (2020 ). Efficient multiresidue determination method for 168 pharmaceuticals and metabolites: optimization and application to raw wastewater, wastewater effluent, and surface water in Beijing, China. Environ. Pollut. 261:114113.

    Not in our library10.1016/j.envpol.2020.114113

  285. 285.

    Zhang Y. Geißen S.-U. (2012 ). Elimination of carbamazepine in a non-sterile fungal bioreactor. Bioresour. Technol. 112 221–227.

    Not in our library10.1016/j.biortech.2012.02.073

  286. 286.

    Zou M. Tian W. Zhao J. Chu M. Song T. (2022 ). Quinolone antibiotics in sewage treatment plants with activated sludge treatment processes: a review on source, concentration and removal. Process Saf. Environ. Prot. 160 116–129.

    Not in our library10.1016/j.psep.2022.02.013

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.